268 results on '"Hyperhomocysteinemia chemically induced"'
Search Results
2. Vitamin B12 status and hyperhomocysteinemia in patients with Rheumatoid arthritis treated with methotrexate and folic acid.
- Author
-
Patel AV, Morgan SL, Green R, Danila MI, Merriman TR, Wanzeck K, Ahmed H, and Gaffo AL
- Subjects
- Humans, Female, Male, Middle Aged, Cross-Sectional Studies, Aged, Homocysteine blood, Adult, Methylmalonic Acid blood, Methotrexate therapeutic use, Methotrexate adverse effects, Folic Acid blood, Folic Acid therapeutic use, Arthritis, Rheumatoid drug therapy, Arthritis, Rheumatoid blood, Hyperhomocysteinemia blood, Hyperhomocysteinemia chemically induced, Hyperhomocysteinemia epidemiology, Vitamin B 12 blood, Antirheumatic Agents therapeutic use, Antirheumatic Agents adverse effects, Vitamin B 12 Deficiency chemically induced, Vitamin B 12 Deficiency blood, Vitamin B 12 Deficiency epidemiology
- Abstract
Background: Rheumatoid arthritis (RA) is an inflammatory arthritis in which the immune system targets synovial joints. Methotrexate serves as the mainstay of treatment for RA due to its efficacy. However, patients treated with methotrexate are uniquely at risk for vitamin B12 deficiency and hyperhomocysteinemia due to coincident disease risk factors and the fact that methotrexate use is associated with malabsorption. The objective of this study was to assess for vitamin B12 deficiency among patients with RA treated with methotrexate and folic acid., Methods: This cross-sectional study included 50 patients with RA treated with methotrexate and folic acid and 49 patients with RA treated with other therapies. Patients were matched by age, sex, race, renal function, and disease activity. We compared plasma vitamin B12, methylmalonic acid, and homocysteine levels between these two groups utilizing quantitative and categorical analyses., Results: Thirty-seven (74%) RA patients on methotrexate and folic acid had elevated plasma homocysteine levels compared with only 27 (55%) RA patients receiving other therapies (P < 0.05). The proportion of patients with low vitamin B12 and high methylmalonic acid levels did not differ between the two groups., Conclusions: Our data show high plasma homocysteine levels among RA patients treated with methotrexate and folic acid. While plasma vitamin B12 levels were similar between the two groups, high plasma homocysteine is also a sensitive marker of vitamin B12 deficiency. Additional studies should evaluate for the presence of clinical features of vitamin B12 deficiency and hyperhomocysteinemia among RA patients treated with methotrexate and folic acid., Competing Interests: Declaration of competing interest Dr. Maria Danila: Pfizer: Research grants UCB: Consultant, ad hoc advisory board, (Published by Elsevier Inc.)
- Published
- 2024
- Full Text
- View/download PDF
3. Folic acid and S-adenosylmethionine reverse Homocysteine-induced Alzheimer's disease-like pathological changes in rat hippocampus by modulating PS1 and PP2A methylation levels.
- Author
-
Sun S, Lu W, Zhang C, Wang G, Hou Y, Zhou J, and Wang Y
- Subjects
- Animals, Rats, Male, Methylation drug effects, Hyperhomocysteinemia metabolism, Hyperhomocysteinemia chemically induced, Neurons drug effects, Neurons metabolism, Neurons pathology, Phosphorylation drug effects, Disease Models, Animal, Hippocampus drug effects, Hippocampus metabolism, Hippocampus pathology, Protein Phosphatase 2 metabolism, S-Adenosylmethionine pharmacology, Alzheimer Disease pathology, Alzheimer Disease metabolism, Alzheimer Disease chemically induced, Homocysteine pharmacology, Homocysteine toxicity, Rats, Wistar, Folic Acid pharmacology, Presenilin-1 genetics, tau Proteins metabolism, Amyloid beta-Peptides metabolism
- Abstract
Background: Abnormally elevated homocysteine (Hcy) is recognized as a biomarker and risk factor for Alzheimer's disease (AD). However, the underlying mechanisms by which Hcy affects AD are still unclear., Objectives: This study aimed to elucidate the effects and mechanisms by which Hcy affects AD-like pathological changes in the hippocampus through in vivo and in vitro experiments, and to investigate whether folic acid (FA) and S-adenosylmethionine (SAM) supplementation could improve neurodegenerative injuries., Methods: In vitro experiments hippocampal neurons of rat were treated with Hcy, FA or SAM for 24 h; while the hyperhomocysteinemia (HHcy) in Wistar rats was established by intraperitoneal injection of Hcy, and FA was added to feed. The expression of β-amyloid (Aβ), phosphorylated tau protein, presenilin 1 (PS1) at the protein level and the activity of protein phosphatase 2A (PP2A) were detected, the immunopositive cells for Aβ and phosphorylated tau protein in the rat hippocampus were also evaluated by immunohistochemical staining., Results: FA and SAM significantly repressed Hcy-induced AD-like pathological changes in the hippocampus, including the increased tau protein phosphorylation at Ser214, Ser396 and the expression of Aβ
42. In addition, Hcy-induced PS1 expression increased at the protein level and PP2A activity decreased, while FA and SAM were able to retard that., Conclusions: The increase in PS1 expression and decrease in PP2A activity may be the mechanisms underlying the Hcy-induced AD-like pathology. FA and SAM significantly repressed the Hcy-induced neurodegenerative injury by modulating PS1 and PP2A methylation levels., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
4. Reference Gene Validation in the Embryonic and Postnatal Brain in the Rat Hyperhomocysteinemia Model.
- Author
-
Kovalenko AA, Schwarz AP, Shcherbitskaia AD, Mikhel AV, Vasilev DS, and Arutjunyan AV
- Subjects
- Female, Pregnancy, Rats, Animals, Rats, Wistar, Brain, Methionine, Racemethionine, Hypoxanthine Phosphoribosyltransferase, Hyperhomocysteinemia chemically induced, Hyperhomocysteinemia genetics
- Abstract
Maternal hyperhomocysteinemia (HCY) induced by genetic defects in methionine cycle enzymes or vitamin imbalance is known to be a pathologic factor that can impair embryonal brain development and cause long-term consequences in the postnatal brain development as well as changes in the expression of neuronal genes. Studies of the gene expression on this model requires the selection of optimal housekeeping genes. This work aimed to analyze the expression stability of housekeeping genes in offspring brain. Pregnant female Wistar rats were treated daily with a 0.15% L-methionine solution in the period starting on the 4th day of pregnancy until delivery, to cause the increase in the homocysteine level in fetus blood and brain. Housekeeping gene expression was assessed by RT-qPCR on whole embryonic brain and selected rat brain areas at P20 and P90. The amplification curves were analyzed, and raw means Cq data were imported to the RefFinder online tool to assess the reference genes stability. Most of the analyzed genes showed high stability of mRNA expression in the fetal brain at both periods of analysis (E14 and E20). However, the most stably expressed genes at different age points differed. Actb, Ppia, Rpl13a are the most stably expressed on E14, Ywhaz, Pgk1, Hprt1 - on E20 and P20, Hprt1, Actb, and Pgk1 - on P90. Gapdh gene used as a reference in various studies demonstrates high stability only in the hippocampus and cannot be recommended as the optimal reference gene on HCY model. Hprt1 and Pgk1 genes were found to be the most stably expressed in the brain of rat subjected to HCY. These two genes showed high stability in the brain on E20 and in various areas of the brain on the P20 and P90. On E14, the preferred genes for normalization are Actb, Ppia, Rpl13a., (© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
5. Effects of Aerobic Treadmill Training on Oxidative Stress Parameters, Metabolic Enzymes, and Histomorphometric Changes in Colon of Rats with Experimentally Induced Hyperhomocysteinemia.
- Author
-
Stojanović M, Todorović D, Gopčević K, Medić A, Labudović Borović M, Despotović S, and Djuric D
- Subjects
- Rats, Male, Animals, Catalase metabolism, Rats, Wistar, Malate Dehydrogenase metabolism, Saline Solution, Oxidative Stress, Superoxide Dismutase metabolism, Homocysteine metabolism, Colon metabolism, Antioxidants pharmacology, Hyperhomocysteinemia chemically induced, Hyperhomocysteinemia metabolism
- Abstract
The aim of this study was to investigate the effects of aerobic treadmill training regimen of four weeks duration on oxidative stress parameters, metabolic enzymes, and histomorphometric changes in the colon of hyperhomocysteinemic rats. Male Wistar albino rats were divided into four groups ( n = 10, per group): C, 0.9% NaCl 0.2 mL/day subcutaneous injection (s.c.) 2x/day; H, homocysteine 0.45 µmol/g b.w./day s.c. 2x/day; CPA, saline (0.9% NaCl 0.2 mL/day s.c. 2x/day) and an aerobic treadmill training program; and HPA, homocysteine (0.45 µmol/g b.w./day s.c. 2x/day) and an aerobic treadmill training program. The HPA group had an increased level of malondialdehyde (5.568 ± 0.872 μmol/mg protein, p = 0.0128 vs. CPA (3.080 ± 0.887 μmol/mg protein)), catalase activity (3.195 ± 0.533 U/mg protein, p < 0.0001 vs. C (1.467 ± 0.501 U/mg protein), p = 0.0012 vs. H (1.955 ± 0.293 U/mg protein), and p = 0.0003 vs. CPA (1.789 ± 0.256 U/mg protein)), and total superoxide dismutase activity (9.857 ± 1.566 U/mg protein, p < 0.0001 vs. C (6.738 ± 0.339 U/mg protein), p < 0.0001 vs. H (6.015 ± 0.424 U/mg protein), and p < 0.0001 vs. CPA (5.172 ± 0.284 U/mg protein)) were detected in the rat colon. In the HPA group, higher activities of lactate dehydrogenase (2.675 ± 1.364 mU/mg protein) were detected in comparison to the CPA group (1.198 ± 0.217 mU/mg protein, p = 0.0234) and higher activities of malate dehydrogenase (9.962 (5.752-10.220) mU/mg protein) were detected in comparison to the CPA group (4.727 (4.562-5.299) mU/mg protein, p = 0.0385). Subchronic treadmill training in the rats with hyperhomocysteinemia triggers the colon tissue antioxidant response (by increasing the activities of superoxide dismutase and catalase) and elicits an increase in metabolic enzyme activities (lactate dehydrogenase and malate dehydrogenase). This study offers a comprehensive assessment of the effects of aerobic exercise on colonic tissues in a rat model of hyperhomocysteinemia, evaluating a range of biological indicators including antioxidant enzyme activity, metabolic enzyme activity, and morphometric parameters, which suggested that exercise may confer protective effects at both the physiological and morphological levels.
- Published
- 2024
- Full Text
- View/download PDF
6. In Situ Fluorescence Imaging Reveals Contribution of Cerebral Hydroxyl Radicals in Hyperhomocysteinemia-Induced Alzheimer-like Dementia.
- Author
-
Xie X, Bian J, Song Y, Liu G, Zhao Y, Zhang J, Li Y, Jiao X, Wang X, and Tang B
- Subjects
- Mice, Animals, Hydroxyl Radical, Risk Factors, Optical Imaging, Homocysteine, Alzheimer Disease diagnostic imaging, Alzheimer Disease complications, Hyperhomocysteinemia complications, Hyperhomocysteinemia chemically induced
- Abstract
Elevated plasma level of homocysteine, also termed as hyperhomocysteinemia, is acknowledged as a significant and independent risk factor of Alzheimer's disease. However, the mechanistic insight has not been thoroughly elucidated yet. In this work, 3,5-dihydroxybenzyloxy was explored as the unique reaction trigger and integrated into the naphthalimide fluorophore via a carbamate linker to afford a new probe for
• OH imaging.• OH treatment induced aromatic hydroxylation and subsequent elimination reaction to release the caged fluorophore, accompanied with a highly specific and sensitive turn-on fluorescence response. Cell imaging results revealed that excess homocysteine triggered overwhelming• OH production, which was mediated by N -methyl-d-aspartate receptor and NADPH oxidase, and the resultant• OH stress further initiated neuronal ferroptosis, also confirmed by western blot analyses. Additionally, hyperhomocysteinemic mouse models were established, and Alzheimer-like dementia of the mice was observed from behavioral tests. Most importantly, with this probe, cerebral• OH fluctuation was in situ visualized in live mice, which positively correlated with the severity of Alzheimer-like dementia induced by hyperhomocysteinemia. These results reveal that cerebral• OH stress may be the critical nexus linking hyperhomocysteinemia and Alzheimer's disease. This work provides a robust fluorescence probe for in situ visualizing the cerebral• OH fluctuations and illuminating critical insights into• OH contributions in brain disorders.- Published
- 2023
- Full Text
- View/download PDF
7. Soluble epoxide hydrolase and TRPC3 channels jointly contribute to homocysteine-induced cardiac hypertrophy: Interrelation and regulation by C/EBPβ.
- Author
-
Zhou Y, Wang XC, Wei JH, Xue HM, Sun WT, He GW, and Yang Q
- Subjects
- Animals, Rats, CCAAT-Enhancer-Binding Protein-beta metabolism, Eicosanoids, Myocardium metabolism, TRPC Cation Channels genetics, TRPC Cation Channels metabolism, Cardiomegaly chemically induced, Cardiomegaly genetics, Cardiomegaly metabolism, Epoxide Hydrolases genetics, Epoxide Hydrolases metabolism, Hyperhomocysteinemia chemically induced, Hyperhomocysteinemia complications
- Abstract
Objectives: Studies in certain cardiac hypertrophy models suggested the individual role of soluble epoxide hydrolase (sEH) and canonical transient receptor potential 3 (TRPC3) channels, however, whether they jointly mediate hypertrophic process remains unexplored. Hyperhomocysteinemia promotes cardiac hypertrophy while the involvement of sEH and TRPC3 channels remains unknown. This study aimed to explore the role of, and interrelation between sEH and TRPC3 channels in homocysteine-induced cardiac hypertrophy., Methods: Rats were fed methionine-enriched diet to induce hyperhomocysteinemia. H9c2 cells and neonatal rat cardiomyocytes were incubated with homocysteine. Cardiac hypertrophy was evaluated by echocardiography, histological examination, immunofluorescence imaging, and expressions of hypertrophic markers. Epoxyeicosatrienoic acids (EETs) were determined by ELISA. TRPC3 current was recorded by patch-clamp. Gene promotor activity was measured using dual-luciferase reporter assay., Results: Inhibition of sEH by 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU) reduced ventricular mass, lowered the expression of hypertrophic markers, decreased interstitial collagen deposition, and improved cardiac function in hyperhomocysteinemic rats, associated with restoration of EETs levels in myocardium. TPPU or knockdown of sEH suppressed TRPC3 transcription and translation as well as TRPC3 current that were enhanced by homocysteine. Exogenous 11,12-EET inhibited homocysteine-induced TRPC3 expression and cellular hypertrophy. Silencing C/EBPβ attenuated, while overexpressing C/EBPβ promoted homocysteine-induced hypertrophy and expressions of sEH and TRPC3, resulting respectively from inhibition or activation of sEH and TRPC3 gene promoters., Conclusions: sEH and TRPC3 channels jointly contribute to homocysteine-induced cardiac hypertrophy. Homocysteine transcriptionally activates sEH and TRPC3 genes through a common regulatory element C/EBPβ. sEH activation leads to an upregulation of TRPC3 channels via a 11,12-EET-dependent manner., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023. Published by Elsevier B.V.)
- Published
- 2023
- Full Text
- View/download PDF
8. Epigallocatechin-3-gallate Enhances Cognitive and Memory Performance and Protects Against Brain Injury in Methionine-induced Hyperhomocysteinemia Through Interdependent Molecular Pathways.
- Author
-
Mostafa MD, ElKomy MA, Othman AI, Amer ME, and El-Missiry MA
- Subjects
- Mice, Male, Animals, Methionine pharmacology, Oxidative Stress, Cognition, Apoptosis Regulatory Proteins, Racemethionine pharmacology, Hyperhomocysteinemia chemically induced, Hyperhomocysteinemia complications, Hyperhomocysteinemia drug therapy, Catechin pharmacology, Catechin therapeutic use, Brain Injuries
- Abstract
Brain injury and cognitive impairment are major health issues associated with neurodegenerative diseases in young and aged persons worldwide. Epigallocatechin-3-gallate (EGCG) was studied for its ability to protect against methionine (Met)-induced brain damage and cognitive dysfunction. Male mice were given Met-supplemented in drinking water to produce hyperhomocysteinemia (HHcy)-induced animals. EGCG was administered daily concurrently with Met by gavage. EGCG attenuated the rise in homocysteine levels in the plasma and the formation of amyloid-β and tau protein in the brain. Cognitive and memory impairment in HHcy-induced mice were significantly improved by EGCG administration. These results were associated with improvement in glutamate and gamma-aminobutyric acid levels in the brain. EGCG maintained the levels of glutathione and the activity of antioxidant enzymes in the brain. As a result of the reduction of oxidative stress, EGCG protected against DNA damage in Met-treated mice. Moreover, maintaining the redox balance significantly ameliorated neuroinflammation evidenced by the normalization of IL-1β, IL-6, tumor necrosis factor α, C-reactive protein, and IL-13 in the same animals. The decreases in both oxidative stress and inflammatory cytokines were significantly associated with upregulation of the antiapoptotic Bcl-2 protein and downregulation of the proapoptotic protein Bax, caspases 3 and 9, and p53 compared with Met-treated animals, indicating a diminution of neuronal apoptosis. These effects reflect and explain the improvement in histopathological alterations in the hippocampus of Met-treated mice. In conclusion, the beneficial effects of EGCG may be due to interconnecting pathways, including modulation of redox balance, amelioration of inflammation, and regulation of antiapoptotic proteins., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
9. Proton pump inhibitor use and its effect on vitamin B12 and homocysteine levels among men and women: A large cross-sectional study.
- Author
-
Lerman TT, Cohen E, Sochat T, Goldberg E, Goldberg I, and Krause I
- Subjects
- Male, Humans, Female, Middle Aged, Vitamin B 12, Cross-Sectional Studies, Proton Pump Inhibitors adverse effects, Homocysteine, Folic Acid, Hyperhomocysteinemia chemically induced, Hyperhomocysteinemia epidemiology, Vitamin B 12 Deficiency chemically induced, Vitamin B 12 Deficiency epidemiology
- Abstract
Background: Previous studies have demonstrated an association between proton pump inhibitors (PPI) use and vitamin B12 deficiency. However, data regarding PPI use and elevated serum homocysteine level, an important marker of vitamin B12 deficiency, are scant., Methods: Data were collected from medical records of subjects examined at a screening center in Israel. Cross sectional analysis was conducted on 25,953 subjects. Levels of vitamin B12 and homocysteine were compared between subjects who consumed PPI medications and those who did not., Results: The mean age of the study population was 45 years and 33% were females. Subjects who received PPI medications had a minor higher vitamin B12 levels (320 pmol/L vs 300 pmol/L, p=0.024). Levels of vitamin B12 remained higher in females receiving PPI medications after performing a stratified analysis according to subjects' gender. Homocysteine levels were higher in subjects receiving PPI medications as compared to those who did not (12.0 μmol/L vs 11.6 0 μmol/L, p<0.001). Levels remained higher in female subjects after performing a stratified analysis according to subjects' sex. There was no statistically significant difference in the prevalence of vitamin B12 deficiency (according to two cutoffs: vitamin B12≤200 or ≤140 pmol/L) as well as the prevalence of hyperhomocysteinemia (defined as homocysteine >15.0 μmol/L) between the two groups., Conclusions: According to our study, no association was found between PPI medication use and vitamin B12 deficiency or hyperhomocysteinemia. Patients receiving PPI medications had slightly higher levels of vitamin B12 and homocysteine, however these differences were too small to have any clinical relevance., Competing Interests: Declaration of Competing Interest Nothing to declare., (Copyright © 2022 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
10. Nitrosative stress induced by homocysteine thiolactone drives vascular cognitive impairments via GTP cyclohydrolase 1 S-nitrosylation in vivo.
- Author
-
Yin YL, Chen Y, Ren F, Wang L, Zhu ML, Lu JX, Wang QQ, Lu CB, Liu C, Bai YP, Wang SX, Wang JZ, and Li P
- Subjects
- Animals, Humans, Mice, Cysteine metabolism, Endothelial Cells metabolism, GTP Cyclohydrolase, Nitric Oxide metabolism, Nitrosative Stress, Cognitive Dysfunction etiology, Cognitive Dysfunction metabolism, Hyperhomocysteinemia chemically induced, Hyperhomocysteinemia metabolism
- Abstract
Background: s: Hyperhomocysteinemia (HHcy) is one of risk factors for vascular cognitive impairment (VCI). GTP cyclohydrolase 1 (GCH1) deficiency is critical to oxidative stress in vascular dysfunction. The aim of this study was designed to examine whether HHcy induces VCI through GCH1 S-nitrosylation, a redox-related post-translational modification of cysteine., Methods: The VCI model was induced by feeding mice homocysteine thiolactone (HTL) for 16 consecutive weeks. The cognitive functions were evaluated by step-down avoidance test, passive avoidance step-through task test, and Morris water maze (MWM) test. Protein S-nitrosylation was assayed using a biotin-switch method., Results: In cell-free system, nitric oxide (NO) donor induced GCH1 protein S-nitrosylation and decreased GCH1 activity. In endothelial cells, HTL increased GCH1 S-nitrosylation, reduced tetrahydrobiopterin, and induced oxidative stress, which were attenuated by N-acetyl-cysteine, L-N6-1-Iminoethyl-lysine, mutant of GCH1 cysteine 141 to alanine (MT-GCH1) or gene deletion of inducible NO synthase (iNOS). Further, HTL incubation or iNOS overexpression promoted endothelial cellular senescence, but abolished by exogenous expression of MT-GCH1 or pharmacological approaches including N-acetyl-cysteine, L-sepiapterin, and tempol. In wildtype mice, long-term administration of HTL induced GCH1 S-nitrosylation and vascular stiffness, decreased cerebral blood flow, and damaged the cognitive functions. However, these abnormalities induced by HTL administration were rescued by enforced expression of MT-GCH1 or gene knockout of iNOS. In human subjects, GCH1 S-nitrosylation was increased and cognitive functions were impaired in patients with HHcy., Conclusion: The iNOS-mediated nitrosative stress induced by HTL drives GCH1 S-nitrosylation to induce cerebral vascular stiffness and cognitive impairments., Competing Interests: Declaration of competing interest We all authors stated that we have no conflicts of interest.Ya-Ling Yin, Yuan Chen, Feng Ren, Lu Wang, Mo–Li Zhu, Jun-Xiu Lu, Qian-Qian Wang, Cheng-Biao Lu, Chao Liu, Yong-Ying Bai, Shuang-Xi Wang, Jian-Zhi WangPeng Li., (Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
11. The Protective Effects of Acetazolamide Against Homocysteine-Induced Blood-Brain-Barrier Disruption by Regulating the Activation of the Wnt/β-Catenin Signaling Pathway.
- Author
-
Li C and Zhang B
- Subjects
- Acetazolamide metabolism, Acetazolamide pharmacology, Animals, Blood-Brain Barrier, Carbonic Anhydrase Inhibitors metabolism, Carbonic Anhydrase Inhibitors pharmacology, Claudin-5 metabolism, Claudin-5 pharmacology, Endothelial Cells metabolism, Homocysteine metabolism, Matrix Metalloproteinase 2 metabolism, Matrix Metalloproteinase 9 metabolism, Mice, Occludin metabolism, Occludin pharmacology, Rats, Wnt Signaling Pathway physiology, beta Catenin metabolism, beta Catenin pharmacology, Brain Diseases metabolism, Hyperhomocysteinemia chemically induced, Hyperhomocysteinemia drug therapy, Hyperhomocysteinemia metabolism, Neuroprotective Agents metabolism, Neuroprotective Agents pharmacology
- Abstract
Acetazolamide (AZA) is a carbonic anhydrase inhibitor (CAI) with neuroprotective effects. Hyperhomocysteinemia is associated with blood-brain-barrier (BBB) disruption in brain disorders. A previous study indicated that AZA might have a new role in brain disorders. However, its function in hyperhomocysteinemia-related BBB disruption has not been reported. Here, we aim to clarify the role of AZA in homocysteine (Hcy)-mediated BBB dysfunction using both in vivo and in vitro assays. We found that AZA improved memory and cognitive function, and reduced brain edema in Hcy-stimulated hyperhomocysteinemia model rats. This protective effect of AZA on hyperhomocysteinemia rats was accompanied by improved BBB permeability and increased expression levels of the tight junction proteins, occludin, and claudin-5. The in vitro assay results show that AZA prevented Hcy-induced cell injury and attenuated the increased permeability in Hcy-treated bEnd.3 brain endothelial cells. The Hcy-induced decrease in occludin and claudin-5, and increase in MMP-2 and MMP-9 expression levels were attenuated by AZA in bEnd.3 cells. Moreover, the Hcy-induced downregulation of the Wnt/β-catenin signaling pathway in bEnd.3 cells was abolished by AZA. Inhibition of Wnt/β-catenin by ICG-001 reversed the protective effects of AZA in Hcy-treated bEnd.3 cells. We also prove that this process is mediated by WTAP. These findings suggest that acetazolamide mitigated the Hcy-induced compromised brain vascular endothelial integrity by regulating the activation of the Wnt/β-catenin signaling pathway., (© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF
12. Rivastigmine Reverses the Decrease in Synapsin and Memory Caused by Homocysteine: Is There Relation to Inflammation?
- Author
-
Ramires Junior OV, Dos Santos TM, Silveira JS, Leite-Aguiar R, Coutinho-Silva R, Savio LEB, and Wyse ATS
- Subjects
- Acetylcholinesterase metabolism, Animals, Homocysteine, Ibuprofen, Inflammation complications, Inflammation drug therapy, Male, Oxidative Stress physiology, Rats, Rats, Wistar, Rivastigmine pharmacology, Rivastigmine therapeutic use, Synapsins metabolism, Hyperhomocysteinemia chemically induced, Hyperhomocysteinemia complications, Hyperhomocysteinemia drug therapy
- Abstract
Elevated levels of homocysteine (Hcy) in the blood, called hyperhomocysteinemia (HHcy), is a prevalent risk factor for it has been shown that Hcy induces oxidative stress and increases microglial activation and neuroinflammation, as well as causes cognitive impairment, which have been linked to the neurodegenerative process. This study aimed to evaluate the effect of mild hyperhomocysteinemia with or without ibuprofen and rivastigmine treatments on the behavior and neurochemical parameters in male rats. The chronic mild HHcy model was chemically induced in Wistar rats by subcutaneous administration of Hcy (4055 mg/kg body weight) twice daily for 30 days. Ibuprofen (40 mg/kg) and rivastigmine (0.5 mg/kg) were administered intraperitoneally once daily. Motor damage (open field, balance beam, rotarod, and vertical pole test), cognitive deficits (Y-maze), neurochemical parameters (oxidative status/antioxidant enzymatic defenses, presynaptic protein synapsin 1, inflammatory profile parameters, calcium binding adapter molecule 1 (Iba1), iNOS gene expression), and cholinergic anti-inflammatory pathway were investigated. Results showed that mild HHcy caused cognitive deficits in working memory, and impaired motor coordination reduced the amount of synapsin 1 protein, altered the neuroinflammatory picture, and caused changes in the activity of catalase and acetylcholinesterase enzymes. Both rivastigmine and ibuprofen treatments were able to mitigate this damage caused by mild HHcy. Together, these neurochemical changes may be associated with the mechanisms by which Hcy has been linked to a risk factor for AD. Treatments with rivastigmine and ibuprofen can effectively reduce the damage caused by increased Hcy levels., (© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF
13. Hyperhomocysteinemia Increases Cortical Excitability and Aggravates Mechanical Hyperalgesia and Anxiety in a Nitroglycerine-Induced Migraine Model in Rats.
- Author
-
Gerasimova E, Yakovleva O, Enikeev D, Bogatova K, Hermann A, Giniatullin R, and Sitdikova G
- Subjects
- Animals, Anxiety, Female, Homocysteine, Hyperalgesia chemically induced, Nitroglycerin toxicity, Photophobia, Pregnancy, Rats, Cortical Excitability, Hyperhomocysteinemia chemically induced, Hyperhomocysteinemia complications, Hyperhomocysteinemia metabolism, Migraine Disorders chemically induced
- Abstract
Homocysteine is a sulfur-containing endogenous amino acid leading to neurotoxic effects at high concentrations. Population studies suggest an association between plasma homocysteine levels and the risk of migraine headaches. The aim of this study was to analyze the sensitivity of rats with prenatal hyperhomocysteinemia (hHCY) in respect of the development of behavioral correlates of headache and spreading cortical depolarization (CSD) in a migraine model induced by the administration of the nitric oxide (NO) donor nitroglycerin. Animals with hHCY were characterized by migraine-related symptoms such as mechanical hyperalgesia, high-level anxiety, photophobia, as well as an enhanced level of neuronal activity in the somatosensory cortex along with a lower threshold of CSD generation. Likewise, acute or chronic intermittent administration of nitroglycerin also induced the development of mechanical allodynia, photophobia and anxiety in control groups. However, these symptoms were more pronounced in rats with hHCY. Unlike hHCY, nitroglycerin administration did not affect the threshold of CSD generation, but like hHCY, increased the background neuronal activity in layers 2/3 and 4 of the cerebral cortex. The latter was more pronounced in animals with hHCY. Thus, the migraine profile associated with hHCY can be further exaggerated in conditions with enhanced levels of migraine triggering the gaseous transmitter NO. Our data are consistent with the view that high levels of plasma homocysteine can act as a risk factor for the development of migraine.
- Published
- 2022
- Full Text
- View/download PDF
14. Effect of hyperhomocysteinemia on rat cardiac sarcoplasmic reticulum.
- Author
-
Tatarkova Z, Bencurova M, Lehotsky J, Racay P, Kmetova Sivonova M, Dobrota D, and Kaplan P
- Subjects
- Animals, Calcium metabolism, Calcium-Binding Proteins metabolism, Calsequestrin metabolism, Heart physiology, Myocardial Contraction, Myocardium metabolism, Rats, Sarcoplasmic Reticulum Calcium-Transporting ATPases, Hyperhomocysteinemia chemically induced, Sarcoplasmic Reticulum metabolism
- Abstract
Increased concentration of plasma homocysteine (Hcy) is an independent risk factor of cardiovascular disease, yet the mechanism by which hyperhomocysteinemia (HHcy) causes cardiac dysfunction is largely unknown. The aim of present study was to investigate the contribution of sarcoplasmic reticulum to impaired cardiac contractile function in HHCy. HHcy-induced by subcutaneous injection of Hcy (0.45 μmol/g of body weight) twice a day for a period of 2 weeks resulted in significant decrease in developed left ventricular pressure and maximum rate of ventricular relaxation. Our results show that abundances of SR Ca
2+ -handling proteins, Ca2+ -ATPase (SERCA2), calsequestrin and histidine-rich calcium-binding protein are significantly reduced while the content of phospholamban is unchanged. Moreover, we found that increased PLN:SERCA2 ratio results in the inhibition of SERCA2 activity at low free Ca2+ concentrations. We further discovered that HHcy is not associated with increased oxidative stress in SR. Taken together, these findings suggest that disturbances in SR Ca2+ handling, caused by altered protein contents but not oxidative damage, may contribute to impaired cardiac contractility in HHcy., (© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)- Published
- 2022
- Full Text
- View/download PDF
15. Tadalafil ameliorates memory deficits, oxidative stress, endothelial dysfunction and neuropathological changes in rat model of hyperhomocysteinemia induced vascular dementia.
- Author
-
Bhatia P and Singh N
- Subjects
- Acetylcholine, Acetylcholinesterase metabolism, Animals, Brain metabolism, Cyclic Nucleotide Phosphodiesterases, Type 5, Maze Learning, Memory Disorders chemically induced, Memory Disorders drug therapy, Methionine, Nitrites blood, Oxidative Stress, Phosphodiesterase 5 Inhibitors, Rats, Rats, Wistar, Dementia, Vascular drug therapy, Dementia, Vascular etiology, Hyperhomocysteinemia chemically induced, Hyperhomocysteinemia complications, Hyperhomocysteinemia drug therapy, Tadalafil therapeutic use
- Abstract
Aim: The present study investigates the potential of Tadalafil, a phosphodiesterase-5 inhibitor, in a rat model of hyperhomocysteinemia induced vascular dementia., Methods: Hyperhomocysteinemia induced vascular dementia in Wistar rats was produced by administering l-Methionine (1.7 g/kg/day; p.o.×8 weeks). Learning and memory was assessed by employing Morris water maze (MWM) test. Endothelial dysfunction was assessed through acetylcholine-induced endothelial-dependent vasorelaxation and serum nitrite levels. Various other biochemical and histopathological estimations were also performed., Results: l-Methionine produced significant impairment in acetylcholine-induced endothelium-dependent vasorelaxation and a decrease in serum nitrite levels indicating endothelial dysfunction. Further, these animals performed poorly on Morris water maze, depicting impairment of learning and memory. There was a significant rise in brain oxidative stress level (indicated by an increase in brain thiobarbituric acid reactive species and a decrease in reduced glutathione levels). Increase in brain acetylcholinesterase activity; brain myeloperoxidase activity and brain neutrophil infiltration (a marker of inflammation) were also observed. Tadalafil (5 and 10 mg/kg, p.o.)/Donepezil (0.5 mg/kg, i.p., serving as standard) treatment ameliorated l-Methionine induced endothelial dysfunction; memory deficits; biochemical and histopathological changes in a significant manner., Conclusions: It may be concluded that tadalafil has shown efficacy in the rat model of l-Methionine induced vascular dementia and that phosphodiesterase-5 can be considered as an important therapeutic target for the treatment of vascular dementia.
- Published
- 2022
- Full Text
- View/download PDF
16. Influence of chronic hyperhomocysteinemia on the features of bone metabolism in the case of lipopolysaccharide-induced periodontitis.
- Author
-
Khudan R, Krynytska I, Marushchak M, and Korda M
- Subjects
- Animals, Lipopolysaccharides adverse effects, Rats, Dental Caries, Hyperhomocysteinemia chemically induced, Hyperhomocysteinemia complications, Hyperhomocysteinemia metabolism, Periodontitis
- Abstract
Background: Periodontal disease is the second most common oral health problem after dental caries. This increasing prevalence makes it not only a health problem, but also a social issue. The pathogenesis of periodontal disease is associated with a number of adverse exogenous and endogenous factors, including hyperhomocysteinemia (HHcy)., Objectives: This study aimed to determine the features of bone metabolism in rats with lipopolysaccharide (LPS)-induced periodontitis combined with chronic thiolactone HHcy., Material and Methods: Forty-eight white, non-linear, mature rats were divided into 4 groups: control (n = 12); LPS‑induced periodontitis (n = 12); chronic thiolactone HHcy (n = 12); and periodontitis combined with HHcy (n = 12). The rats were sacrificed the day after the last LPS injection or the day after the last homocysteine (Hcy) thiolactone administration. Bone metabolism was determined based on the activity of alkaline phosphatase (ALP) and acid phosphatase (AP) in blood serum and periodontal homogenate., Results: A decrease in ALP activity (by 40.1%; р = 0.001) and the mineralization index (MI) (3.5 times; р < 0.001) with an increase in AP activity (2.0 times; р < 0.001) was observed in the periodontal homogenate of rats with LPS‑induced periodontitis. In the case of LPS‑induced periodontitis combined with chronic thiolactone HHcy, more pronounced changes in the activity of phosphatases and in MI were established as compared to rats with LPS‑induced periodontitis only., Conclusions: Chronic thiolactone HHcy enhances disturbances in bone metabolism in LPS‑induced periodontitis. The osteotoxic effect of HHcy is associated with the activation of osteoclastogenesis and enhanced bone resorption. However, further research is required on the subject.
- Published
- 2022
- Full Text
- View/download PDF
17. Hyperhomocysteinemia Induces Rat Memory Impairment Via Injuring Hippocampal CA3 Neurons and Downregulating cAMP Response Element-Binding Protein (CREB) Phosphorylation.
- Author
-
Liu C, Zhao H, Ji ZH, and Yu XY
- Subjects
- Animals, Hippocampus metabolism, Neurons metabolism, Phosphorylation, Rats, Cyclic AMP Response Element-Binding Protein metabolism, Hyperhomocysteinemia chemically induced, Hyperhomocysteinemia complications, Memory Disorders
- Abstract
Accumulated evidence demonstrated that an elevated plasma homocysteine level, hyperhomocysteinemia, induced cognitive impairment in animals, elderly and the patients with neurodegenerative diseases. To date, the underlying cellular and molecular mechanisms by which hyperhomocysteinemia induces cognitive impairment has not been clearly defined. The purpose of this study was to investigate the possible cellular and molecular mechanisms behind hyperhomocysteinemia signaling in rat memory impairment. The results from this study demonstrated that hyperhomocysteinemia induced neuronal damage and loss in hippocampal CA3 region and downregulated the cAMP response element-binding protein (CREB) phosphorylation. The findings of this study provide evidence that hyperhomocysteinemia induces rat memory impairment via injuring hippocampal CA3 neurons and downregulating CREB phosphorylation., (© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF
18. A chronic moderate methionine administration induced hyperhomocysteinemia associated with cardiovascular disease phenotype in the sand rat Psammomys obesus.
- Author
-
Zerrouk F, Chaouad B, Ghoul A, Chalour N, Moulahoum A, Khiari Z, Cherifi MEH, Aouichat S, Houali K, and Benazzoug Y
- Subjects
- Animals, Gerbillinae, Methionine, Phenotype, Cardiovascular Diseases chemically induced, Cardiovascular Diseases complications, Hyperhomocysteinemia chemically induced, Hyperhomocysteinemia complications, Hyperhomocysteinemia pathology
- Abstract
Introduction: Cardiovascular diseases were defined as coronary artery, cerebrovascular, or peripheral arterial disease. Hyperhomocysteinemia (Hhcy) is an independent risk factor of cardiovascular diseases, including atherosclerosis. Our previous studies demonstrated the involvement of Hhcy in cardiovascular remodeling in the sand rat Psammomys obesus., Material and Methods: An experimental Hhcy was induced, in the sand rat Psammomys obesus, by a daily intraperitoneal injection of 70 mg/kg of methionine for a total duration of 6 months. The impact of Hhcy on the cellular and matrix structures of the heart, aorta and liver was analyzed using histological techniques. Additionally we treatedprimary cultures of aortic smooth muscle cells (SMCs) with high concentration of methionine to investigate the effects of methionine at the cellular level., Results: A moderate Hhcy induced a significant increase in the extracellular matrix components particularly collagens which accumulated in the interstitial and perivascular spaces in the studied organs indicating a developing fibrosis. A liver steatosis was also observed following methionine treatment. Further analysis of the aorta showed that Hhcy also induced vascular alterations including SMCs reorientation and proliferation associated with aneurysm formation., Conclusions: Our results show for the first time that Hhcy can induce a cardiovascular and liver diseases phenotype in Psammomys obesus, a species previously shown to be a good model for the studies of diabetes and other metabolism-related pathologies.
- Published
- 2022
- Full Text
- View/download PDF
19. PROTEOLYTIC ACTIVITY IN THE HEART OF RATS WITH HYPERHOMOCYSTEINEMIA.
- Author
-
Raksha N, Maievskyi O, Dzevulska I, Kaminsky R, Samborska I, Savchuk O, and Kovalchuk О
- Subjects
- Animals, Male, Rats, Cytokines metabolism, Heart, Hyperhomocysteinemia chemically induced, Hyperhomocysteinemia metabolism, Serine Proteases metabolism
- Abstract
Objective: The aim: To investigate the distribution of proteolytic activity and cytokine profile in the heart of rats with hyperhomocysteinemia., Patients and Methods: Materials and methods: A total of 60 albino non-linear male rats was used in the study. Hyperhomocysteinemia was induced by intragastric administration of DL-homocysteine thiolactone. Total proteolytic activity was measured using casein as a substrate. To determine the activity of metal-dependent and serine proteases, ethylenediaminetetraacetic acid, and phenylmethylsulfonyl fluoride were used. The level of matrix metalloproteinases, tissue inhibitor of metalloproteinases-1, and cytokines was studied by enzyme-linked immunosorbent assay., Results: Results: It was found an increase in the total proteolytic activity in the heart of young, adult, and old animals. In addition, the redistribution of proteolytic activity was revealed - the portion of metal-dependent enzymes increased in all groups while the percentage of serine proteases decreased in the old animals with hyperhomocysteinemia. The state of mild inflammation, evidenced by the increased level of some pro-inflammatory cytokines, was found in the heart of young and old animals with hyperhomocysteinemia., Conclusion: Conclusions: The pathogenesis of hyperhomocysteinemia is accompanied by a change in the proteolytic activity in the heart as well as a change in the cytokine profile.
- Published
- 2022
- Full Text
- View/download PDF
20. Safety of Dietary Guanidinoacetic Acid: A Villain of a Good Guy?
- Author
-
Ostojic SM
- Subjects
- Aged, Animals, Creatine blood, Creatine urine, Energy Metabolism drug effects, Glycine administration & dosage, Glycine adverse effects, Homocysteine blood, Humans, Hyperhomocysteinemia chemically induced, Methylation drug effects, Risk Assessment, Creatine metabolism, Dietary Supplements adverse effects, Glycine analogs & derivatives
- Abstract
Guanidinoacetic acid (GAA) is a natural amino acid derivative that is well-recognized for its central role in the biosynthesis of creatine, an essential compound involved in cellular energy metabolism. GAA (also known as glycocyamine or betacyamine) has been investigated as an energy-boosting dietary supplement in humans for more than 70 years. GAA is suggested to effectively increase low levels of tissue creatine and improve clinical features of cardiometabolic and neurological diseases, with GAA often outcompeting traditional bioenergetics agents in maintaining ATP status during stress. This perhaps happens due to a favorable delivery of GAA through specific membrane transporters (such as SLC6A6 and SLC6A13), previously dismissed as un-targetable carriers by other therapeutics, including creatine. The promising effects of dietary GAA might be countered by side-effects and possible toxicity. Animal studies reported neurotoxic and pro-oxidant effects of GAA accumulation, with exogenous GAA also appearing to increase methylation demand and circulating homocysteine, implying a possible metabolic burden of GAA intervention. This mini-review summarizes GAA toxicity evidence in human nutrition and outlines functional GAA safety through benefit-risk assessment and multi-criteria decision analysis.
- Published
- 2021
- Full Text
- View/download PDF
21. THE INFLUENCE OF CHRONIC HYPERHOMOCYSTEINEMIA ON PHAGOCYTIC AND METABOLIC ACTIVITY OF PERIPHERAL BLOOD NEUTROPHILS IN CASE OF LIPOPOLYSACCHARIDE-INDUCED PERIODONTITIS.
- Author
-
Khudan R, Bandas I, Mykolenko A, Svanishvili N, and Krynytska I
- Subjects
- Animals, Lipopolysaccharides toxicity, Male, Neutrophils, Phagocytosis, Rats, Hyperhomocysteinemia chemically induced, Hyperhomocysteinemia complications, Periodontitis complications
- Abstract
The aim of the study was to investigate the phagocytic and metabolic activity of peripheral blood neutrophils in rats with lipopolysaccharide (LPS)-induced periodontitis combined with chronic thiolactone hyperhomocysteinemia (HHcy).The experiment included non-linear mature male rats (n=48), which were divided into 4 groups: control; animals with a periodontitis model; animals with a model of chronic thiolactone HHcy; animals with a model of periodontitis in combination with chronic thiolactone HHcy. Phagocytic activity, phagocytic index and phagocytic number were determined as indicators of phagocytosis of peripheral blood neutrophils. The oxygen-dependent bactericidal activity of peripheral blood neutrophils was studied using nitroblue tetrazolium test (NBT-test).Our research has found that LPS-induced periodontitis in rats is accompanied by dysfunction of phagocytosis process (increased phagocytic activity with a simultaneous decrease of absorption capacity) and activation of oxygen-dependent microbicidal mechanisms of peripheral blood neutrophils, as indicated by an increase of indices of spontaneous and activated NBT-test. Chronic thiolactone HHcy adversely affects the functional and metabolic activity of peripheral blood neutrophils in case of periodontitis, which is confirmed by a violation of the process of phagocytosis, a more pronounced decrease in absorption capacity and depletion of metabolic reserves of these cells in rats with comorbid course of LPS-induced periodontitis vs. animals with only LPS-induced periodontitis. The observed disorders in the process of phagocytosis in rats with comorbid course of periodontitis are an important factor in reducing the non-specific organism resistance which contributes to the progression of periodontitis. The obtained results reveal new aspects of the high Hcys plasma level influence on the course of inflammatory process in periodontal tissues, which opens opportunities for improving pathogenetic therapy in patients with periodontal disease combined with chronic HHcy.
- Published
- 2021
22. Hyperhomocysteinemia increases susceptibility to cortical spreading depression associated with photophobia, mechanical allodynia, and anxiety in rats.
- Author
-
Gerasimova E, Burkhanova G, Chernova K, Zakharov A, Enikeev D, Khaertdinov N, Giniatullin R, and Sitdikova G
- Subjects
- Animals, Anxiety etiology, Cortical Spreading Depression drug effects, Disease Models, Animal, Female, Hyperalgesia etiology, Hyperhomocysteinemia chemically induced, Male, Methionine pharmacology, Migraine with Aura etiology, Photophobia etiology, Pregnancy, Prenatal Exposure Delayed Effects chemically induced, Rats, Rats, Wistar, Anxiety physiopathology, Behavior, Animal physiology, Cortical Excitability physiology, Cortical Spreading Depression physiology, Hyperalgesia physiopathology, Hyperhomocysteinemia complications, Photophobia physiopathology, Somatosensory Cortex physiopathology
- Abstract
Epidemiological data suggest that elevated homocysteine is associated with migraine with aura. However, how homocysteine contributes to migraine is still unclear. Here, we tested whether hyperhomocysteinemia (hHCY) promotes cortical spreading depression (CSD), a phenomenon underlying migraine with aura, and whether hHCY contributes to pain behavior. hHCY was induced by dietary methionine in female rats while the testing was performed on their 6-8week-old offspring. CSD and multiple unit activity (MUA) induced by KCl were recorded from the primary somatosensory cortex, S1, using multichannel electrodes. In hHCY rats, compared to control, we found: i) higher probability of CSD occurrence; ii) induction of CSD by lower concentrations of KCl; iii) faster horizontal propagation of CSD; iv) smaller CSD with longer duration; v) higher frequency of MUA at CSD onset along with slower reappearance. Rats with hHCY demonstrated high level of locomotor activity and grooming while spent less time in the central area of the open field, indicating anxiety. These animals showed light sensitivity and facial mechanical allodinia. Thus, hHCY acquired at birth promotes multiple features of migraine such as higher cortical excitability, mechanical allodynia, photophobia, and anxiety. Our results provide the first experimental explanation for the higher occurrence of migraine with aura in patients with hHCY., (Copyright © 2021 Elsevier B.V. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
23. Homocysteine and Gliotoxicity.
- Author
-
Wyse ATS, Bobermin LD, Dos Santos TM, and Quincozes-Santos A
- Subjects
- Animals, Astrocytes drug effects, Astrocytes metabolism, Astrocytes pathology, Gliosis chemically induced, Gliosis metabolism, Gliosis pathology, Humans, Hyperhomocysteinemia chemically induced, Hyperhomocysteinemia metabolism, Hyperhomocysteinemia pathology, Neurodegenerative Diseases pathology, Neuroglia pathology, Homocysteine metabolism, Homocysteine toxicity, Neurodegenerative Diseases chemically induced, Neurodegenerative Diseases metabolism, Neuroglia drug effects, Neuroglia metabolism
- Abstract
Homocysteine is a sulfur amino acid that does not occur in the diet, but it is an essential intermediate in normal mammalian metabolism of methionine. Hyperhomocysteinemia results from dietary intakes of Met, folate, and vitamin B12 and lifestyle or from the deficiency of specific enzymes, leading to tissue accumulation of this amino acid and/or its metabolites. Severe hyperhomocysteinemic patients can present neurological symptoms and structural brain abnormalities, of which the pathogenesis is poorly understood. Moreover, a possible link between homocysteine (mild hyperhomocysteinemia) and neurodegenerative/neuropsychiatric disorders has been suggested. In recent years, increasing evidence has emerged suggesting that astrocyte dysfunction is involved in the neurotoxicity of homocysteine and possibly associated with the physiopathology of hyperhomocysteinemia. This review addresses some of the findings obtained from in vivo and in vitro experimental models, indicating high homocysteine levels as an important neurotoxin determinant of the neuropathophysiology of brain damage. Recent data show that this amino acid impairs glutamate uptake, redox/mitochondrial homeostasis, inflammatory response, and cell signaling pathways. Therefore, the discussion of this review focuses on homocysteine-induced gliotoxicity, and its impacts in the brain functions. Through understanding the Hcy-induced gliotoxicity, novel preventive/therapeutic strategies might emerge for these diseases.
- Published
- 2021
- Full Text
- View/download PDF
24. Effects of vitamin B12, folate, and entacapone on homocysteine levels in levodopa-treated Parkinson's disease patients: A randomized controlled study.
- Author
-
Anamnart C and Kitjarak R
- Subjects
- Aged, Female, Folic Acid therapeutic use, Homocysteine drug effects, Humans, Hyperhomocysteinemia chemically induced, Hyperhomocysteinemia prevention & control, Levodopa therapeutic use, Male, Middle Aged, Research Design, Vitamin B 12 therapeutic use, Antiparkinson Agents therapeutic use, Catechols therapeutic use, Homocysteine blood, Nitriles therapeutic use, Parkinson Disease blood, Parkinson Disease drug therapy
- Abstract
Introduction: Previous studies have suggested a significant increase in plasma homocysteine (Hcy) levels in levodopa-treated Parkinson's disease (PD) patients, and vitamin B12 and folate supplementation may decrease Hcy levels. However, the effects of catechol-O-methyltransferase inhibitors on levodopa-induced increase in Hcy levels were conflicting. The aim of this study was to evaluate whether Hcy levels are increased in levodopa-treated PD patients and to evaluate the effects of vitamin B12 and folate or entacapone on Hcy levels in levodopa-treated PD patients., Methods: We analyzed and compared plasma Hcy levels in 20 levodopa-naïve PD patients and 42 levodopa-treated PD patients, followed by randomized assignment of 42 levodopa-treated patients to treatment groups with either vitamin B12 and folate, entacapone, or no medication., Results: Plasma Hcy levels in levodopa-treated PD patients were higher than those in the control group, but the difference was not statistical significant (15.25 ± 6.70 and 13.13 ± 4.68, P = 0.216). Patients treated with vitamin B12 and folate had a significant decrease in plasma Hcy levels (P < 0.001). In the entacapone group, Hcy levels were mildly decreased, but the change did not reach statistical significance., Conclusion: Levodopa-treated PD patients had higher plasma Hcy than levodopa-naive PD patients. Unlike entacapone, combination supplementation with vitamin B12 and folate was associated with significantly decreased plasma Hcy. We suggest that plasma Hcy levels should be monitored during levodopa treatment, and supplementation with inexpensive vitamin B12 and folate is beneficial for levodopa-treated patients., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2021 Elsevier Ltd. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
25. Implementation of programmed cell death in circulating neutrophils and its special characteristics in experimentally induced hyperhomocysteinemia in a setting of thyroid dysfunction.
- Author
-
Nechyporuk V, Korda M, Pentiuk L, Kovalchuk O, and Andriichuk V
- Subjects
- Animals, Apoptosis, Homocysteine, Neutrophils, Rats, Reactive Oxygen Species, Hyperhomocysteinemia chemically induced, Hyperhomocysteinemia complications
- Abstract
Cardiovascular (CV) disease continues to be the main cause of morbidity and mortality in worldwide. Hyperhomocysteinemia (HHCy) is a novel metabolic risk factor of vascular damage. In addition to that, there is evidence that HHCy management with folic acid and vitamin B supplements prevents atherosclerosis and its sequelae. Oxidative stress is one of the mechanisms behind the cardiotoxic effects of high homocysteine levels. On the one hand, HHCy facilitates endothelial dysfunction, probably as a result of impaired synthesis and/or inactivation of nitrogen (II) oxide (NO). On the other hand, oxidation of homocysteine is accompanied by formation of reactive oxygen species (ROS), which induce lipid peroxidation in cell membranes and in low density lipoproteins, mitochondrial membrane, secretion of cytochrome C and activation of caspase-3, culminating in apoptosis. Thyroid hormones are known to have a profound effect on CV functions. Hyperthyroidism causes heart rate, myocardial contractility and ejection fraction to increase; this may result in systolic hypertension, systolic heart murmurs, increased left ventricular weight and development of angina and atrial fibrillation with a risk for stroke., Aim: The aim of our work was to investigate into the special aspects that characterize implementation of programmed cell death in circulating neutrophils of HHCy rats either without comorbidities or with hyper- or hypothyroidism., Materials and Methods: Prolonged hyperthyroidism and hypothyroidism were modeled in experimental rats by dosing the animals with Lthyroxine and thiamazole, respectively, for 21 days, and prolonged with HHCy administered with excessive exogenous HCy, for 21 days. Prolonged HHCy rats with hyper- or hypothyroidism were observed., Results: We have found the count of circulating neutrophils with increased ROS production and reduced transmembrane mitochondrial potential to be significantly increased in rats with HHCy compared to control animals, which suggests prooxidant properties of HCy and its ability to cause mitochondrial dysfunction. The intensity of ROS production by circulating neutrophils in hyperthyroid animals with HHCy was not significantly different from that in hyperthyroid rats without HHCy. In hypothyroid rats with HHCy, ROS production by circulating neutrophils was significantly higher compared to the control group. HCys increased ROS generation in kidney mitochondria while strongly decreasing it in liver, heart and brain mitochondria showing that the changes are tissue-specific. We have found the count of circulating neutrophils with signs of apoptosis to be increased in rats with HHCy compared to the control group., Conclusions: Experimentally induced HHCy is accompanied by hyperproduction of reactive oxygen species and by impaired integrity of external mitochondrial membrane, which results in initiation of apoptotic cell death. The deficiency of thyroid hormones enhances initiation of programmed cell death., (© 2020 MEDPRESS.)
- Published
- 2020
26. Maternal Hyperhomocysteinemia Induces Neuroinflammation and Neuronal Death in the Rat Offspring Cortex.
- Author
-
Shcherbitskaia AD, Vasilev DS, Milyutina YP, Tumanova NL, Zalozniaia IV, Kerkeshko GO, and Arutjunyan AV
- Subjects
- Animals, Animals, Newborn, Apoptosis, Brain metabolism, Brain pathology, Caspase 3 metabolism, Cerebral Cortex pathology, Disease Models, Animal, Female, Hyperhomocysteinemia chemically induced, Inflammation pathology, Interleukin-1beta metabolism, Interleukin-6 metabolism, Methionine toxicity, Neuroglia metabolism, Neuroglia pathology, Neurons pathology, Pregnancy, Pregnancy Complications chemically induced, Rats, Tumor Necrosis Factor-alpha metabolism, p38 Mitogen-Activated Protein Kinases metabolism, Cerebral Cortex metabolism, Hyperhomocysteinemia metabolism, Inflammation metabolism, Neurons metabolism, Pregnancy Complications metabolism
- Abstract
Maternal hyperhomocysteinemia is one of the common complications of pregnancy that causes offspring cognitive deficits during postnatal development. In the present work, we evaluated the effect of prenatal hyperhomocysteinemia on structural and ultrastructural organization, neuronal and glial cell number, apoptosis (caspase-3 content and activity), inflammatory markers (tumor necrosis factor-α, interleukin-6, and interleukin-1β), and p38 mitogen-activated protein kinase (p38 MAPK) phosphorylation in the offspring brain cortex in early ontogenesis. Wistar female rats received methionine (0.6 g/kg body weight) by oral administration during pregnancy. Histological and biochemical analyses of 5- and 20-day-old pups' cortical tissue were performed. Lysosome accumulation and other neurodegenerative changes in neurons of animals with impaired embryonic development were investigated by electron microscopy. Neuronal staining (anti-NeuN) revealed a reduction in neuronal number, accompanied by increasing of caspase-3 active form protein level and activity. Maternal hyperhomocysteinemia also elevated the number of astroglial and microglial cells and increased expression of interleukin-1β and p38 MAPK phosphorylation, which indicates the development of neuroinflammatory processes.
- Published
- 2020
- Full Text
- View/download PDF
27. Nicorandil reversed homocysteine-induced coronary microvascular dysfunction via regulating PI3K/Akt/eNOS pathway.
- Author
-
Zhan B, Xu Z, Zhang Y, Wan K, Deng H, Wang D, Bao H, Wu Q, Hu X, Wang H, Huang X, and Cheng X
- Subjects
- Animals, Cell Survival drug effects, Cells, Cultured, Chromones pharmacology, Endothelial Cells drug effects, Homocysteine, Humans, Hyperhomocysteinemia chemically induced, Hypoxia, Male, Mice, Morpholines pharmacology, Myocardial Infarction physiopathology, Myocardial Infarction prevention & control, NG-Nitroarginine Methyl Ester pharmacology, Nicorandil antagonists & inhibitors, Plant Lectins biosynthesis, Platelet Endothelial Cell Adhesion Molecule-1 biosynthesis, Ventricular Function, Left physiology, Hyperhomocysteinemia prevention & control, Microcirculation physiology, Nicorandil pharmacology, Nitric Oxide Synthase Type III metabolism, Phosphatidylinositol 3-Kinases metabolism, Proto-Oncogene Proteins c-akt metabolism
- Abstract
Objective: Nicorandil exerts a protective effect against coronary microvascular dysfunction in acute myocardial infarction (AMI) patients. However, the mechanism and effect of nicorandil in hyperhomocysteinemia (HHcy) AMI patients remain unclear., Methods: C57/BL6 mice with mild to moderate HHcy and human coronary artery endothelial cells (HCAECs) cotreated with HHcy (1 mmol/L) for 24 h and hypoxia for 6 h were selected as models. Small animal ultrasound detection was used to compare cardiac function. CD31 immunofluorescence staining and tomato lectin staining were used to assess the number of microcirculation changes in vivo. MTT, tube formation and western blotting assays were used to evaluate the effect of nicorandil on HCAECs and the PI3K/Akt/eNOS pathway., Results: The results showed that nicorandil improved cell viability and p-PI3K/PI3K, p-Akt/Akt, and p-eNOS/eNOS expression in the vitro HHcy and hypoxia models. The beneficial effects of nicorandil on HCAECs could be inhibited by the phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 and the nitric oxide synthase (NOS) inhibitor L-NAME. In vivo, nicorandil improved the left ventricular ejection fraction (LVEF) and left ventricular fractional shortening (LVFS) in the post-HHcy + MI model, and the levels of CD31 and tomato lectin expression were higher in the nicorandil treatment group. The effectiveness of nicorandil was inhibited in the PI3K and L-NAME groups., Conclusion: The results suggest that nicorandil improves Hcy-induced coronary microvascular dysfunction through the PI3K/Akt/eNOS signalling pathway., Competing Interests: Declaration of Competing Interest The authors declare that they have no competing interests., (Copyright © 2020 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
28. Melatonin rescued methotrexate-induced spatial deficit and hyperhomocysteinemia and increased asymmetric dimethylarginine in plasma and dorsal hippocampus in developing rats.
- Author
-
Chen YC, Sheen JM, Hsu MH, Hsiao CC, Wang SC, and Huang LT
- Subjects
- Animals, Animals, Newborn, Arginine analysis, Arginine blood, Disease Models, Animal, Male, Maze Learning drug effects, Methotrexate antagonists & inhibitors, Rats, Rats, Sprague-Dawley, Antimetabolites, Antineoplastic adverse effects, Arginine analogs & derivatives, Hippocampus chemistry, Hyperhomocysteinemia chemically induced, Melatonin pharmacology, Methotrexate adverse effects, Spatial Behavior drug effects
- Abstract
Aims: With the improvement of the survival rates in children acute lymphoblastic leukemia (ALL), some children ALL survivors show impaired cognitive function. Methotrexate (MTX), an essential component in ALL treatment, has been reported to be related to neurologic sequelae and to increased oxidative stress through its interactions with enzymes in the folate pathway. Asymmetric dimethylarginine (ADMA) is the main endogenous inhibitor of nitric oxide synthase, and increased ADMA may result from increased oxidants. Melatonin is an antioxidant; however, its role in MTX neuropathy is not well studied. We developed a rat model mimicking child ALL treatment to explore peripheral and central homocysteine and ADMA regulation after MTX and found potential treatment choice., Main Methods: Preweaning male Sprague-Dawley rats were used in this study. Experiment 1 evaluated spatial performance in rats with intrathecal (IT) MTX, intraperitoneal (IP) MTX, or combined IT and IP MTX, protocols mimicking ALL treatment in children. Experiment 2 focused on rats with combined IT and IP MTX, evaluating spatial performance and plasma and dorsal hippocampal homocysteine and ADMA levels, their regulation, and the protective effect of melatonin., Key Findings: Combined IT and IP MTX treatment caused in spatial deficits in developing rats, and melatonin restored the spatial performance. Alterations in peripheral and central homocysteine and ADMA concentrations and their regulation were found and could be alleviated by melatonin treatment., Significances: Combined IP and IT MTX treatment caused spatial deficits in developing rats. Melatonin could restore spatial performance through alleviating the effects on the imbalance of oxidative stress., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
29. Chronic mild hyperhomocysteinemia induces anxiety-like symptoms, aversive memory deficits and hippocampus atrophy in adult rats: New insights into physiopathological mechanisms.
- Author
-
Wyse ATS, Sanches EF, Dos Santos TM, Siebert C, Kolling J, and Netto CA
- Subjects
- Adenosine Triphosphate metabolism, Animals, Anxiety pathology, Atrophy etiology, Atrophy pathology, Avoidance Learning, Chronic Disease, DNA Damage physiology, Electron Transport Complex IV metabolism, Hippocampus physiopathology, Homocysteine blood, Hyperhomocysteinemia chemically induced, Male, Memory Disorders physiopathology, Open Field Test, Oxidative Stress physiology, Rats, Rats, Wistar, Anxiety etiology, Hippocampus pathology, Hyperhomocysteinemia complications, Memory Disorders etiology
- Abstract
In the last decade, increased homocysteine levels have been implicated as a risk factor for neurodegenerative and psychiatric disorders. We have developed an experimental model of chronic mild hyperhomocysteinemia (HHcy) in order to observe metabolic impairments in the brain of adult rodents. Besides its known effects on brain metabolism, the present study sought to investigate whether chronic mild HHcy could induce learning/memory impairments associated with biochemical and histological damage to the hippocampus. Adult male Wistar rats received daily subcutaneous injections of homocysteine (0.03 μmol/g of body weight) twice a day, from the 30th to the 60th day of life or saline solution (Controls). After injections, anxiety-like and memory tests were performed. Following behavioral analyses, brains were sliced and hippocampal volumes assessed and homogenized for redox state assessment, antioxidant activity, mitochondrial functioning (chain respiratory enzymes and ATP levels) and DNA damage analyses. Behavioral analyses showed that chronic mild HHcy may induce anxiety-like behavior and impair long-term aversive memory (24 h) that was evaluated by inhibitory avoidance task. Mild HHcy decreased locomotor and/or exploratory activities in elevated plus maze test and caused hippocampal atrophy. Decrease in cytochrome c oxidase, DNA damage and redox state changes were also observed in hippocampus of adult rats subjected to mild HHcy. Our findings show that chronic mild HHcy alters biochemical and histological parameters in the hippocampus, leading to behavioral impairments. These findings might be considered in future studies aiming to search for alternative strategies for treating the behavioral impairments in patients with mild elevations in homocysteine levels., (Copyright © 2019 Elsevier B.V. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
30. Neurotrophins of the Fetal Brain and Placenta in Prenatal Hyperhomocysteinemia.
- Author
-
Arutjunyan AV, Milyutina YP, Shcherbitskaia AD, Kerkeshko GO, Zalozniaia IV, and Mikhel AV
- Subjects
- Animals, Brain embryology, Cytokines metabolism, Female, Hyperhomocysteinemia chemically induced, Hyperhomocysteinemia pathology, Methionine administration & dosage, Nervous System embryology, Nervous System metabolism, Pregnancy, Rats, Rats, Wistar, Brain metabolism, Hyperhomocysteinemia metabolism, Nerve Growth Factors metabolism, Nervous System chemistry, Placenta metabolism
- Abstract
Prenatal hyperhomocysteinemia (PHHC) in pregnant rats was induced by chronic L-methionine loading, resulting in a significant increase in the L-homocysteine content both in the mothers' blood and blood and brain of fetuses. Significant decrease in the weight of the placenta, fetus, and fetal brain was detected by the morphometric studies on day 20 of pregnancy. PHHC also activated maternal immune system due to the increase in the content of proinflammatory interleukin-1β in the rat blood and fetal part of the placenta. PHHC elevated the levels of the brain-derived neurotrophic factor (BDNF, 29 kDa) and nerve growth factor (NGF, 31 kDa) precursors in the placenta and the content of the BDNF isoform (29 kDa) in the fetal brain. The content of neuregulin 1 (NRG1) decreased in the placenta and increased in the fetal brain on day 20 of embryonic development. An increase in the caspase-3 activity was detected in the brains of fetuses subjected to PHHC. It was suggested that changes in the processing of neurotrophins induced by PPHC, oxidative stress, and inflammatory processes initiated by it, as well as apoptosis, play an important role in the development of brain disorders in the offspring.
- Published
- 2020
- Full Text
- View/download PDF
31. IL‑37 expression is decreased in patients with hyperhomocysteinemia and protects cells from inflammatory injury by homocysteine.
- Author
-
Wang S, Huang Z, Li W, He S, Wu H, Zhu J, Li R, Liang Z, and Chen Z
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Gene Expression Regulation drug effects, Homocysteine pharmacology, Homocysteine toxicity, Humans, Hydro-Lyases blood, Hyperhomocysteinemia chemically induced, Hyperhomocysteinemia complications, Hyperhomocysteinemia genetics, Inflammation chemically induced, Inflammation complications, Inflammation genetics, Interleukin-1 blood, Interleukin-1beta blood, Interleukin-6 blood, Male, Middle Aged, RNA, Messenger blood, Tumor Necrosis Factor-alpha blood, Tumor Necrosis Factor-alpha genetics, Homocysteine metabolism, Hyperhomocysteinemia blood, Inflammation blood, Interleukin-1 genetics
- Abstract
As a novel anti‑inflammatory cytokine of the interleukin (IL)‑1 family, IL‑37 protects the human body from diseases characterized by excessive inflammation. The pathologic process of hyperhomocysteinemia (hHcy) is accompanied by persistent inflammation. However, little is known regarding the role of IL‑37 in hHcy. In the present study, the levels of cytokines including IL‑37, IL‑1β, IL‑6 and tumor necrosis factor‑α in the supernatant were detected by ELISA. mRNA and protein expression were detected by Reverse transcription‑quantitative PCR and western blotting, respectively. LDH level was determined by ELISA and the cell viability was detected through CCK‑8 kit. In the present study, mean serum IL‑37 levels of patients with hHcy were 32.3% lower than those of controls (P<0.01). In peripheral blood mononuclear cells (PBMCs) from patients with hHcy, mean IL‑37 mRNA expression was 73.5% lower (P<0.01) and IL‑37 protein expression was 77.7% lower compared with that of healthy controls (P<0.01). Furthermore, the results demonstrated that exogenous homocysteine (Hcy) stimulation markedly downregulated the mRNA and protein expression levels of IL‑37 in PBMCs in vitro. In 293T cells, overexpression of IL‑37 restored the cell viability impaired by Hcy, and reduced the release of lactate dehydrogenase and the proinflammatory cytokines IL‑1β, IL‑6 and tumor necrosis factor‑α. In conclusion, IL‑37 was downregulated by Hcy in vivo and in vitro, and IL‑37 exhibited a protective role against cell injury induced by Hcy.
- Published
- 2020
- Full Text
- View/download PDF
32. Effect of Methionine Diet on Metabolic and Histopathological Changes of Rat Hippocampus.
- Author
-
Kovalska M, Hnilicova P, Kalenska D, Tothova B, Adamkov M, and Lehotsky J
- Subjects
- Animals, Disease Models, Animal, Hippocampus drug effects, Hippocampus metabolism, Hyperhomocysteinemia chemically induced, Hyperhomocysteinemia metabolism, Male, Organ Size drug effects, Proton Magnetic Resonance Spectroscopy, Rats, Rats, Wistar, Hippocampus diagnostic imaging, Hyperhomocysteinemia diagnostic imaging, Metabolome drug effects, Methionine adverse effects
- Abstract
Hyperhomocysteinemia (hHcy) is regarded as an independent and strong risk factor for cerebrovascular diseases, stroke, and dementias. The hippocampus has a crucial role in spatial navigation and memory processes and is being constantly studied for neurodegenerative disorders. We used a moderate methionine (Met) diet at a dose of 2 g/kg of animal weight/day in duration of four weeks to induce mild hHcy in adult male Wistar rats. A novel approach has been used to explore the hippocampal metabolic changes using proton magnetic resonance spectroscopy (1H MRS), involving a 7T MR scanner in combination with histochemical and immunofluorescence analysis. We found alterations in the metabolic profile, as well as remarkable histo-morphological changes such as an increase of hippocampal volume, alterations in number and morphology of astrocytes, neurons, and their processes in the selective vulnerable brain area of animals treated with a Met-enriched diet. Results of both methodologies suggest that the mild hHcy induced by Met-enriched diet alters volume, histo-morphological pattern, and metabolic profile of hippocampal brain area, which might eventually endorse the neurodegenerative processes.
- Published
- 2019
- Full Text
- View/download PDF
33. Hyperhomocysteinemia and myocardial remodeling in the sand rat, Psammomys obesus.
- Author
-
Chaouad B, Moudilou EN, Ghoul A, Zerrouk F, Moulahoum A, Othmani-Mecif K, Cherifi MEH, Exbrayat JM, and Benazzoug Y
- Subjects
- Animals, Gerbillinae, Methionine adverse effects, Methionine pharmacology, Apoptosis, Cardiomyopathies chemically induced, Cardiomyopathies metabolism, Cardiomyopathies pathology, Hyperhomocysteinemia chemically induced, Hyperhomocysteinemia metabolism, Hyperhomocysteinemia pathology, Muscle Proteins biosynthesis, Myocardium metabolism, Myocardium pathology, Myocytes, Cardiac metabolism, Myocytes, Cardiac pathology
- Abstract
Objective: Numerous studies have shown that a methionine-rich diet induces hyperhomocysteinemia (Hhcy), a risk factor for cardiovascular diseases. The objective of the present study was to determine the involvement of Hhcy in cardiac remodeling in the sand rat Psammomys obesus., Materials and Methods: An experimental Hhcy was induced, in the sand rat Psammomys obesus, by intraperitoneal injection of 300 mg/kg of body weight/day of methionine for 1 month. The impact of Hhcy on the cellular and matricial structures of the myocardium was analyzed with histological techniques (Masson trichrome and Sirius red staining). Immunohistochemistry allowed us to analyze several factors involved in myocardial remodeling, such as fibrillar collagen I and III, metalloproteases (MMP-2 and -9) and their inhibitors (TIMP-1 and -2), TGF-β1 and activated caspase 3., Results: Our results show that Hhcy induced by an excess of methionine causes, in the myocardium of Psammomys obesus, a significant accumulation of fibrillar collagens I and III at the interstitial and perivascular scales, indicating the appearance of fibrosis, which is associated with an immuno-expression increase of TGF-β1, MMP-9 and TIMP-2 and an immuno-expression decrease of MMP-2 and TIMP-1. Also, Hhcy induces apoptosis of some cardiomyocytes and cardiac fibroblasts by increasing of activated caspase 3 expression. These results highlight a remodeling of cardiac tissue in hyperhomocysteinemic Psammomys obesus., (Copyright © 2019 Elsevier GmbH. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
34. Severe hyperhomocysteinemia and peripheral neuropathy as side effects of nitrous oxide in two patients with sickle cell disease.
- Author
-
Neveu J, Perelman S, Suisse G, and Monpoux F
- Subjects
- Adolescent, Anesthetics, Inhalation therapeutic use, Female, Humans, Hyperhomocysteinemia diagnosis, Male, Median Nerve drug effects, Median Nerve physiopathology, Nitrous Oxide therapeutic use, Peripheral Nervous System Diseases diagnosis, Peroneal Nerve drug effects, Peroneal Nerve physiopathology, Severity of Illness Index, Tibial Nerve drug effects, Tibial Nerve physiopathology, Anemia, Sickle Cell drug therapy, Anesthetics, Inhalation adverse effects, Hyperhomocysteinemia chemically induced, Nitrous Oxide adverse effects, Peripheral Nervous System Diseases chemically induced
- Abstract
Nitrous oxide (N
2 O) is a widely used anesthetic agent. We report two patients with sickle cell disease (SCD) who presented with complications following the use of N2 O. Patient 1, a 15-year-old girl, presented severe hyperhomocysteinemia, pancytopenia, vitamin B12 deficiency, and peripheral polyneuropathy after massive use of N2 O for pain management. At the 1-year follow-up, hyperhomocysteinemia and B12 deficiency had resolved, but she had persisting mild symptoms of polyneuropathy. Patient 2, a 17-year-old boy, presented only severe hyperhomocysteinemia, only partially corrected by initial B12 supplementation. Careful monitoring of N2 O use, especially in patients with SCD, is mandatory to prevent complications., (Copyright © 2019 French Society of Pediatrics. Published by Elsevier Masson SAS. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF
35. Human tissue kallikrein-1 protects against the development of erectile dysfunction in a rat model of hyperhomocysteinemia.
- Author
-
Cui K, Luan Y, Tang Z, Li CC, Wang T, Wang SG, Chen Z, and Liu JH
- Subjects
- Animals, Apoptosis, Diet, Endothelial Cells, Erectile Dysfunction pathology, Fibrosis, Humans, Hyperhomocysteinemia chemically induced, Male, Methionine, Oxidative Stress, Penis pathology, Rats, Rats, Sprague-Dawley, Rats, Transgenic, Signal Transduction genetics, Erectile Dysfunction etiology, Erectile Dysfunction prevention & control, Hyperhomocysteinemia complications, Tissue Kallikreins genetics
- Abstract
The aim of this study was to investigate the mechanism by which a diet inducing high hyperhomocysteinemia (HHcy) leads to the deterioration of erectile function in rats and whether this is inhibited by expression of the human tissue kallikrein-1 (hKLK1) gene. We established a rat model of HHcy by feeding methionine (Met)-rich diets to male Sprague-Dawley (SD) rats. Male wild-type SD rats (WTRs) and transgenic rats harboring the hKLK1 gene (TGRs) were fed a normal diet until 10 weeks of age. Then, 30 WTRs were randomly divided into three groups as follows: the control (n = 10) group, the low-dose (4% Met, n = 10) group, and the high-dose (7% Met, n = 10) group. Another 10 age-matched TGRs were fed the high-dose diet and designated as the TGR+7% Met group. After 30 days, in all four groups, erectile function was measured and penile tissues were harvested to determine oxidative stress, endothelial cell content, and penis fibrosis. Compared with the 7% Met group, the TGR+7% Met group showed diminished HHcy-induced erectile dysfunction (ED), indicating the improvement caused by hKLK1. Regarding corpus cavernosum endothelial cells, hKLK1 preserved endothelial cell-cell junctions and endothelial cell content, and activated protein kinase B/endothelial nitric oxide synthase (Akt/eNOS) signaling. Fibrosis assessment indicated that hKLK1 preserved normal penis structure by inhibiting apoptosis in the corpus cavernosum smooth muscle cells. Taken together, these findings showed that oxidative stress, impaired corpus cavernosum endothelial cells, and severe penis fibrosis were involved in the induction of ED by HHcy in rats, whereas hKLK1 preserved erectile function by inhibiting these pathophysiological changes., Competing Interests: None
- Published
- 2019
- Full Text
- View/download PDF
36. Liraglutide Ameliorates Hyperhomocysteinemia-Induced Alzheimer-Like Pathology and Memory Deficits in Rats via Multi-molecular Targeting.
- Author
-
Zhang Y, Xie JZ, Xu XY, Hu J, Xu T, Jin S, Yang SJ, and Wang JZ
- Subjects
- Alzheimer Disease metabolism, Alzheimer Disease pathology, Amyloid beta-Peptides, Animals, Brain metabolism, Disease Models, Animal, Hippocampus metabolism, Hyperhomocysteinemia chemically induced, Hyperhomocysteinemia metabolism, Hyperhomocysteinemia pathology, Insulin Resistance, Male, Maze Learning, Memory Disorders drug therapy, Neuronal Plasticity, Neuroprotective Agents pharmacology, Phosphorylation drug effects, Rats, Rats, Sprague-Dawley, Receptors, Neurotransmitter, tau Proteins metabolism, Alzheimer Disease drug therapy, Alzheimer Disease etiology, Hyperhomocysteinemia drug therapy, Liraglutide pharmacology, Liraglutide therapeutic use
- Abstract
Hyperhomocysteinemia (Hhcy) is an independent risk factor for Alzheimer's disease (AD), and insulin-resistance is commonly seen in patients with Hhcy. Liraglutide (Lir), a glucagon-like peptide that increases the secretion and sensitivity of insulin, has a neurotrophic or neuroprotective effect. However, it is not known whether Lir ameliorates the AD-like pathology and memory deficit induced by Hhcy. By vena caudalis injection of homocysteine to produce the Hhcy model in rats, we found here that simultaneous administration of Lir for 2 weeks ameliorated the Hhcy-induced memory deficit, along with increased density of dendritic spines and up-regulation of synaptic proteins. Lir also attenuated the Hhcy-induced tau hyperphosphorylation and Aβ overproduction, and the molecular mechanisms involved the restoration of protein phosphatase-2A activity and inhibition of β- and γ-secretases. Phosphorylated insulin receptor substrate-1 also decreased after treatment with Lir. Our data reveal that Lir improves the Hhcy-induced AD-like spatial memory deficit and the mechanisms involve the modulation of insulin-resistance and the pathways generating abnormal tau and Aβ.
- Published
- 2019
- Full Text
- View/download PDF
37. Anti-Ischemic Activity of Triamine ALM-802 under Conditions of Endothelial Dysfunction.
- Author
-
Barchukov VV, Tsorin IB, Likhosherstov AM, Vititnova MB, Mokrov GV, Gudasheva TA, and Kryzhanovskii SA
- Subjects
- Animals, Electrophysiology, Hyperhomocysteinemia chemically induced, Isoproterenol toxicity, Male, Myocardial Infarction chemically induced, Rats, Hyperhomocysteinemia drug therapy, Myocardial Infarction drug therapy, Ranolazine therapeutic use, Trimetazidine therapeutic use
- Abstract
Anti-ischemic activity of N1-(2,3,4-trimethoxybenzyl)-N2-{2-[(2,3,4-trimethoxybenzyl)amino] ethyl}-1,2-ethanediamine (ALM-802) based on the structure of standard p-FOX inhibitors trimetazidine and ranolazine was studied on the model of endocardial ischemia in intact rats and animals with endothelial dysfunction. Acute endocardial myocardial ischemia was caused by infusion of isoproterenol (20 μg/kg/min intravenously). Endothelial dysfunction in rats was modeled by inducing hyperhomocysteinemia (3 g/kg methionine intragastrically one a day over 7 days). The reference drugs trimetazidine (30 mg/kg, intravenously) and ranolazine 10 mg/kg, intravenously) that were effective only in intact rats. In contrast, ALM-802 (2 mg/kg, intravenously) showed a pronounced anti-ischemic effect in animals with endothelial dysfunction, which suggests that the mechanisms of its cardioprotective action differ from those known for p-FOX inhibitors.
- Published
- 2019
- Full Text
- View/download PDF
38. Double-sidedness of "laughing gas" on the N-methyl-d-aspartate receptor: A case report of acute psychosis associated with nitrous oxide-induced hyperhomocysteinemia.
- Author
-
Kim S, Lee SH, and Bang M
- Subjects
- Female, Hallucinations metabolism, Hallucinations psychology, Humans, Hydroxocobalamin therapeutic use, Hyperhomocysteinemia complications, Hyperhomocysteinemia metabolism, Psychotic Disorders metabolism, Psychotic Disorders psychology, Vitamin B 12 Deficiency chemically induced, Vitamin B 12 Deficiency drug therapy, Vitamin B 12 Deficiency metabolism, Vitamin B Complex therapeutic use, Young Adult, Hallucinations etiology, Hyperhomocysteinemia chemically induced, Nitrous Oxide adverse effects, Psychotic Disorders etiology, Receptors, N-Methyl-D-Aspartate metabolism
- Published
- 2019
- Full Text
- View/download PDF
39. Methanolic extract of Tamarix Gallica attenuates hyperhomocysteinemia induced AD-like pathology and cognitive impairments in rats.
- Author
-
Salissou MTM, Mahaman YAR, Zhu F, Huang F, Wang Y, Xu Z, Ke D, Wang Q, Liu R, Wang JZ, Zhang B, and Wang X
- Subjects
- Animals, Male, Memory Disorders drug therapy, Methanol, Neurons drug effects, Oxidative Stress drug effects, Phosphorus Compounds, Phosphotransferases metabolism, Phytotherapy, Plant Extracts chemistry, Rats, Rats, Sprague-Dawley, tau Proteins metabolism, Alzheimer Disease chemically induced, Alzheimer Disease drug therapy, Homocysteine toxicity, Hyperhomocysteinemia chemically induced, Plant Extracts pharmacology, Tamaricaceae chemistry
- Abstract
Although few drugs are available today for the management of Alzheimer's disease (AD) and many plants and their extracts are extensively employed in animals' studies and AD patients, yet no drug or plant extract is able to reverse AD symptoms adequately. In the present study, Tamarix gallica (TG), a naturally occurring plant known for its strong antioxidative, anti-inflammatory and anti-amyloidogenic properties, was evaluated on homocysteine (Hcy) induced AD-like pathology and cognitive impairments in rats. We found that TG attenuated Hcy-induced oxidative stress and memory deficits. TG also improved neurodegeneration and neuroinflammation by upregulating synaptic proteins such as PSD95 and synapsin 1 and downregulating inflammatory markers including CD68 and GFAP with concomitant decrease in proinflammatory mediators interlukin-1β (IL1β) and tumor necrosis factor α (TNFα). TG attenuated tau hyperphosphorylation at multiple AD-related sites through decreasing some kinases and increasing phosphatase activities. Moreover, TG rescued amyloid-β (Aβ) pathology through downregulating BACE1. Our data for the first time provide evidence that TG attenuates Hcy-induced AD-like pathological changes and cognitive impairments, making TG a promising candidate for the treatment of AD-associated pathological changes.
- Published
- 2018
- Full Text
- View/download PDF
40. Diet-induced hyperhomocysteinemia impairs vasodilation in 5/6-nephrectomized rats.
- Author
-
Li L, Hasegawa H, Inaba N, Yoshioka W, Chang D, Liu J, and Ichida K
- Subjects
- Acetylcholine, Animals, Diet adverse effects, Endothelium, Vascular physiopathology, Homocysteine blood, Humans, Hyperhomocysteinemia chemically induced, Hyperhomocysteinemia metabolism, Kidney physiopathology, Kidney surgery, Male, Methionine metabolism, Nephrectomy, Rats, Rats, Sprague-Dawley, Renal Insufficiency, Chronic chemically induced, Renal Insufficiency, Chronic metabolism, Hyperhomocysteinemia physiopathology, Methionine adverse effects, Renal Insufficiency, Chronic physiopathology, Vasodilation
- Abstract
Plasma homocysteine is elevated in patients with impaired renal function, and markedly so at end-stage renal disease. As chronic kidney disease and hyperhomocysteinemia are also independent risk factors for cardiovascular disease, the latter is hypothesized to accelerate vascular abnormalities following renal failure. This study aimed to investigate the combined effect of impaired renal function and hyperhomocysteinemia on vascular function. We show that in 5/6-nephrectomized rats, a model of chronic kidney disease, a methionine-rich diet for 8 weeks induces moderate hyperhomocysteinemia, exacerbates hypertension, and attenuates the vascular response to acetylcholine, sodium nitroprusside, 8-bromo-cGMP, and isoprenaline. However, plasma nitrate/nitrite and total NOS activity in the thoracic aorta were not affected. Collectively, the data imply that hyperhomocysteinemia and end-stage renal disease synergistically impair endothelium-dependent and endothelium-independent vasodilatation by blocking the cGMP/protein kinase G and/or cAMP/protein kinase A pathways. 5/6-Nephrectomized rat with hyperhomocysteinemia induced by a methionine-rich diet would be a useful model for elucidating the pathogenesis of vascular impairment in patients with end-stage renal disease.
- Published
- 2018
- Full Text
- View/download PDF
41. Association of Induced Hyperhomocysteinemia with Alzheimer's Disease-Like Neurodegeneration in Rat Cortical Neurons After Global Ischemia-Reperfusion Injury.
- Author
-
Kovalska M, Tothova B, Kovalska L, Tatarkova Z, Kalenska D, Tomascova A, Adamkov M, and Lehotsky J
- Subjects
- Alzheimer Disease chemically induced, Animals, Cerebral Cortex drug effects, Hyperhomocysteinemia chemically induced, Male, Nerve Degeneration chemically induced, Rats, Rats, Wistar, Reperfusion Injury chemically induced, Alzheimer Disease pathology, Cerebral Cortex pathology, Homocysteine toxicity, Hyperhomocysteinemia pathology, Nerve Degeneration pathology, Reperfusion Injury pathology
- Abstract
Alzheimer's disease (AD) is a progressive and irreversible neurodegenerative disorder that results in massive hippocampal and neocortical neuronal loss leading to dementia and eventual death. The exact cause of Alzheimer's disease is not fully explored, although a number of risk factors have been recognized, including high plasma concentration of homocysteine (Hcy). Hyperhomocysteinemia (hHcy) is considered a strong, independent risk factor for stroke and dementia. However, the molecular background underlying these mechanisms linked with hHcy and ischemic stroke is not fully understood. Paper describes rat model of global forebrain ischemia combined with the experimentally induced hHcy. Global ischemia-reperfusion injury (IRI) was developed by 4-vessels occlusion lasting for 15 min followed by reperfusion period of 72 h. hHcy was induced by subcutaneous injection of 0.45 µmol/g of Hcy in duration of 14 days. The results showed remarkable neural cell death induced by hHcy in the brain cortex and neurodegeneration is further aggravated by global IRI. We demonstrated degeneration of cortical neurons, alterations in number and morphology of tissue astrocytes and dysregulation of oxidative balance with increased membrane protein oxidation. Complementary to, an immunohistochemical analysis of tau protein and β-amyloid peptide showed that combination of hHcy with the IRI might lead to the progression of AD-like pathological features. Conclusively, these findings suggest that combination of risk factor hHcy with IRI aggravates neurodegeneration processes and leads to development of AD-like pathology in cerebral cortex.
- Published
- 2018
- Full Text
- View/download PDF
42. Vitamin B complex mitigates cardiac dysfunction in high-methionine diet-induced hyperhomocysteinemia.
- Author
-
Jeremic J, Nikolic Turnic T, Zivkovic V, Jeremic N, Milosavljevic I, Srejovic I, Obrenovic R, Jancic S, Rakocevic M, Matic S, Djuric D, and Jakovljevic V
- Subjects
- Animals, Catalase metabolism, Glutathione metabolism, Homocysteine metabolism, Hyperhomocysteinemia chemically induced, Hyperhomocysteinemia metabolism, Hyperhomocysteinemia pathology, Male, Rats, Rats, Wistar, Reactive Oxygen Species metabolism, Superoxide Dismutase metabolism, Diet, Heart drug effects, Heart physiopathology, Hyperhomocysteinemia physiopathology, Methionine adverse effects, Vitamin B Complex pharmacology
- Abstract
This research is designed to test the hypothesis that elevated homocysteine (Hcy) levels in vivo, caused by a deficit in vitamin B complex, promote changes in cardiac function and redox status that lead to heart failure. In order to conduct the study, we used adult male Wistar albino rats (n = 30; 4 weeks old; 100 ± 15 g body weight). Hyperhomocysteinaemia (HHcy) in these animals was achieved by dietary manipulation. For 4 weeks, the animals were fed with a standard rodent chow (control, CF), a diet enriched in methionine with no deficiency in B vitamins (i.e., folic acid, B6 and B12) (HMNV) or a diet enriched in methionine and deficient in B vitamins (HMLV). After 28 days of dietary manipulation, all animals were killed. The rat hearts were isolated and retrogradely perfused according to the Langendorff technique at a gradually increasing perfusion pressure. We found a negative correlation between elevated serum Hcy and total body and heart weight. The maximum rate of left ventricular pressure development was significantly increased in the HMNV group compared with in the other groups. Systolic left ventricular pressure was significantly changed in all groups. HHcy induces remodelling of the cardiac tissues, as moderate HHcy is associated with more prominent interstitial and perivascular fibrosis. Our results suggest that a high methionine diet without vitamin B complex causes profound negative effects associated with HHcy., (© 2018 John Wiley & Sons Australia, Ltd.)
- Published
- 2018
- Full Text
- View/download PDF
43. Efficacy of Folic Acid and Vitamin B 12 Replacement Therapies in the Reduction of Adverse Effects of Isotretinoin: A Randomized Controlled Trial.
- Author
-
Ghiasi M, Mortazavi H, and Jafari M
- Subjects
- Acne Vulgaris drug therapy, Adolescent, Adult, Female, Humans, Hyperhomocysteinemia chemically induced, Male, Young Adult, Dermatologic Agents adverse effects, Folic Acid therapeutic use, Hyperhomocysteinemia prevention & control, Isotretinoin adverse effects, Vitamin B 12 therapeutic use, Vitamin B Complex therapeutic use
- Abstract
Previous studies have reported elevated homocysteine levels and folic acid and/or vitamin B
12 deficiencies after isotretinoin therapy, which increase the risk of cardiovascular and neuropsychiatric disorders. Homocysteine is metabolized in the liver, a process requiring folate and vitamin B12 . We conducted a randomized controlled trial to investigate whether folate and vitamin B12 replacement therapy with isotretinoin would be useful for preventing hyperhomocysteinemia. A total of 66 patients with acne were randomized into two groups: group A took isotretinoin, folic acid, and vitamin B12 , whereas group B took isotretinoin alone. Treatment was continued for 2 months. Blood homocysteine, folic acid, and vitamin B12 levels were measured before and after treatment. In group A, a significant decrease in homocysteine level was observed after treatment (P=.0004), although it was still within the normal range. Folic acid and vitamin B12 levels significantly increased (P=.0026 and P=.0002, respectively). In group B, no significant changes were observed in the levels of homocysteine and vitamin B12 , but folic acid levels decreased significantly (P=.02). We concluded that folic acid and vitamin B12 supplementation during isotretinoin therapy could be useful for preventing folate deficiency and improving blood homocysteine levels; this might as a result reduce the risks for cardiovascular and neuropsychiatric disorders in patients taking isotretinoin.- Published
- 2018
44. Chronic Mild Hyperhomocysteinemia Alters Inflammatory and Oxidative/Nitrative Status and Causes Protein/DNA Damage, as well as Ultrastructural Changes in Cerebral Cortex: Is Acetylsalicylic Acid Neuroprotective?
- Author
-
de S Moreira D, Figueiró PW, Siebert C, Prezzi CA, Rohden F, Guma FCR, Manfredini V, and Wyse ATS
- Subjects
- Animals, Anti-Inflammatory Agents, Non-Steroidal pharmacology, Aspirin pharmacology, Catalase metabolism, Comet Assay, DNA Damage drug effects, Dendritic Spines drug effects, Dendritic Spines ultrastructure, Disease Models, Animal, Dose-Response Relationship, Drug, Homocysteine toxicity, Hyperhomocysteinemia chemically induced, Hyperhomocysteinemia pathology, Male, Oxidative Stress, Rats, Rats, Wistar, Superoxide Dismutase metabolism, Acetylcholinesterase metabolism, Cerebral Cortex pathology, Cerebral Cortex ultrastructure, Cytokines metabolism, Hyperhomocysteinemia complications, Nitrites metabolism
- Abstract
Homocysteine is a sulfur-containing amino acid derived from methionine metabolism. When plasma homocysteine levels exceed 10-15 μM, there is a condition known as hyperhomocysteinemia, which occur as a result of an inborn error of methionine metabolism or by non-genetic causes. Mild hyperhomocysteinemia is considered a risk factor for development of neurodegenerative diseases. The objective of the present study was to evaluate whether acetylsalicylic acid has neuroprotective role on the effect of homocysteine on inflammatory, oxidative/nitrative stress, and morphological parameters in cerebral cortex of rats subjected to chronic mild hyperhomocysteinemia. Wistar male rats received homocysteine (0.03 μmol/g of body weight) by subcutaneous injections twice a day and acetylsalicylic acid (25 mg/Kg of body weight) by intraperitoneal injections once a day from the 30th to the 60th postpartum day. Control rats received vehicle solution in the same volume. Results showed that rats subjected to chronic mild hyperhomocysteinemia significantly increased IL-1β, IL-6, and acetylcholinesterase activity and reduced nitrite levels. Homocysteine decreased catalase activity and immunocontent and superoxide dismutase activity, caused protein and DNA damage, and altered neurons ultrastructure. Acetylsalicylic acid totally prevented the effect of homocysteine on acetylcholinesterase activity and catalase activity and immunocontent, as well as the ultrastructural changes, and partially prevented alterations on IL-1β levels, superoxide dismutase activity, sulfhydryl content, and comet assay. Acetylsalicylic acid per se increased DNA damage index. In summary, our findings showed that chronic chemically induced model of mild hyperhomocysteinemia altered some parameters and acetylsalicylic acid administration seemed to be neuroprotective, at least in part, on neurotoxicity of homocysteine.
- Published
- 2018
- Full Text
- View/download PDF
45. Exercise intervention attenuates hyperhomocysteinemia-induced aortic endothelial oxidative injury by regulating SIRT1 through mitigating NADPH oxidase/LOX-1 signaling.
- Author
-
Chan SH, Hung CH, Shih JY, Chu PM, Cheng YH, Lin HC, Hsieh PL, and Tsai KL
- Subjects
- Animals, Atherosclerosis etiology, Atherosclerosis prevention & control, Carbazoles pharmacology, Carbazoles therapeutic use, Endothelium, Vascular drug effects, Endothelium, Vascular metabolism, Hyperhomocysteinemia chemically induced, Hyperhomocysteinemia complications, Hyperhomocysteinemia drug therapy, Male, Malondialdehyde blood, Methionine toxicity, Mice, Mice, Inbred C57BL, NADPH Oxidase 1 antagonists & inhibitors, NF-kappa B metabolism, Neuropeptides metabolism, Oxidative Stress drug effects, Physical Conditioning, Animal, Signal Transduction drug effects, Sirtuin 1 antagonists & inhibitors, Superoxide Dismutase blood, Up-Regulation drug effects, rac1 GTP-Binding Protein metabolism, NADPH Oxidase 1 metabolism, Scavenger Receptors, Class E metabolism, Sirtuin 1 metabolism
- Abstract
Coronary artery disease (CAD) is a critical cardiovascular disease and a cause of high morbidity and mortality in this world. Hyperhomocysteinemia (HHcy) has been suggested as a risk factor for CAD. In addition, SIRT1 (sirtuin 1) has been reported to play a protective role in a variety of diseases, especially in the cardiovascular system. The main purpose of this study was to investigate the effects of exercise training on apoptosis and inflammation in HHcy animals. We also tested whether exercise protected against Hhcy-induced dysfunction of endothelium through modulation of SIRT1. C57BL mice (8 in each group) were fed with or without 1% L-methionine (w/w) in water for 4 months to induce HHcy. We found that Hhcy repressed SIRT1 and AMPK expression and increased NADPH oxidase activity. Plasma MDA, endothelium LOX-1 and p-p38 were up-regulated by Hhcy induction. NF-κB and it downstream molecules were activated under Hhcy situation, thereby promoting pro-inflammatory responses. Moreover, we also reported that Hhcy caused endothelium apoptosis involving Akt inhibition and mitochondria-dependent apoptotic pathways. Exercise training significantly protected against endothelium from Hhcy caused oxidative injuries. In addition, EX527 (SIRT1 inhibitor) reduced the therapeutic effects by exercise. Our results had indicated that exercise training prevent the development of atherosclerosis through SIRT1 activation and oxidative stress inhibition under Hhcy situation., (Copyright © 2017 Elsevier B.V. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
46. Exercise Mitigates Alcohol Induced Endoplasmic Reticulum Stress Mediated Cognitive Impairment through ATF6-Herp Signaling.
- Author
-
George AK, Behera J, Kelly KE, Mondal NK, Richardson KP, and Tyagi N
- Subjects
- Analysis of Variance, Animals, Behavior, Animal, Blood Pressure physiology, Blood-Brain Barrier physiopathology, Capillary Permeability physiology, Cerebrovascular Circulation physiology, Epigenesis, Genetic physiology, Ethanol administration & dosage, Ethanol adverse effects, Exercise Test, Exercise Therapy, Homocysteine metabolism, Hyperhomocysteinemia chemically induced, Hyperhomocysteinemia therapy, Male, Mice, Mice, Inbred C57BL, Models, Animal, Normal Distribution, Oxidative Stress physiology, Activating Transcription Factor 6 metabolism, Cognitive Dysfunction metabolism, Endoplasmic Reticulum Stress physiology, Ethanol metabolism, Membrane Proteins metabolism, Physical Conditioning, Animal physiology
- Abstract
Chronic ethanol/alcohol (AL) dosing causes an elevation in homocysteine (Hcy) levels, which leads to the condition known as Hyperhomocysteinemia (HHcy). HHcy enhances oxidative stress and blood-brain-barrier (BBB) disruption through modulation of endoplasmic reticulum (ER) stress; in part by epigenetic alternation, leading to cognitive impairment. Clinicians have recommended exercise as a therapy; however, its protective effect on cognitive functions has not been fully explored. The present study was designed to observe the protective effects of exercise (EX) against alcohol-induced epigenetic and molecular alterations leading to cerebrovascular dysfunction. Wild-type mice were subjected to AL administration (1.5 g/kg-bw) and subsequent treadmill EX for 12 weeks (5 day/week@7-11 m/min). AL affected mouse brain through increases in oxidative and ER stress markers, SAHH and DNMTs alternation, while decreases in CBS, CSE, MTHFR, tight-junction proteins and cellular H
2 S levels. Mechanistic study revealed that AL increased epigenetic DNA hypomethylation of Herp promoter. BBB dysfunction and cognitive impairment were observed in the AL treated mice. AL mediated transcriptional changes were abolished by administration of ER stress inhibitor DTT. In conclusion, exercise restored Hcy and H2 S to basal levels while ameliorating AL-induced ER stress, diminishing BBB dysfunction and improving cognitive function via ATF6-Herp-signaling. EX showed its protective efficacy against AL-induced neurotoxicity.- Published
- 2018
- Full Text
- View/download PDF
47. Effects of atorvastatin and simvastatin on oxidative stress in diet-induced hyperhomocysteinemia in Wistar albino rats: a comparative study.
- Author
-
Nikolic T, Zivkovic V, Srejovic I, Stojic I, Jeremic N, Jeremic J, Radonjic K, Stankovic S, Obrenovic R, Djuric D, and Jakovljevic V
- Subjects
- Animals, Catalase blood, Hyperhomocysteinemia blood, Hyperhomocysteinemia chemically induced, Hyperhomocysteinemia drug therapy, Male, Rats, Rats, Wistar, Superoxide Dismutase blood, Superoxides blood, Thiobarbituric Acid Reactive Substances metabolism, Atorvastatin pharmacology, Diet adverse effects, Oxidative Stress drug effects, Simvastatin pharmacology
- Abstract
Considering the well-known antioxidant properties of statins, it seems important to assess their impact on major markers of oxidative stress (superoxide anion radical, nitric oxide, and index of lipid peroxidation) to compare the antioxidative potentials of atorvastatin and simvastatin during the different degrees of hyperhomocysteinemia (HHcy) in rats. This study was conducted on adult male Wistar albino rats (n = 90; 4 weeks old; 100 ± 15 g body mass) in which HHcy was achieved by dietary manipulation. For 4 weeks, the animals were fed with one of the following diets: standard rodent chow, diet enriched in methionine with no deficiency in B vitamins (folic acid, B6, and B12), or diet enriched in methionine and deficient in B vitamins (folic acid, B6, and B12). At the same time, animals were treated with atorvastatin at doses of 3 mg/kg/day i.p. or simvastatin at doses of 5 mg/kg/day i.p. Levels of superoxide anion radical and TBARS were significantly decreased by administration of simvastatin in normal and high-homocysteine (Hcy) groups (p < 0.05). At 4 weeks after feeding with purified diets, the concentrations of the GSH, CAT, and SOD antioxidants were significantly affected among all groups (p < 0.05). Our results indicated that statin therapy had variable effects on the redox status in hyperhomocysteinemic rats, and simvastatin demonstrated stronger antioxidant effects than did atorvastatin.
- Published
- 2018
- Full Text
- View/download PDF
48. Hesperidin, a citrus flavonoid, protects against l-methionine-induced hyperhomocysteinemia by abrogation of oxidative stress, endothelial dysfunction and neurotoxicity in Wistar rats.
- Author
-
Hemanth Kumar B, Dinesh Kumar B, and Diwan PV
- Subjects
- Acetylcholinesterase metabolism, Animals, Brain metabolism, Brain physiopathology, Cholesterol blood, Cognition drug effects, Cytoprotection, Disease Models, Animal, Donepezil, Dose-Response Relationship, Drug, Endothelium, Vascular metabolism, Endothelium, Vascular physiopathology, GPI-Linked Proteins metabolism, Homocysteine blood, Hyperhomocysteinemia blood, Hyperhomocysteinemia chemically induced, Hyperhomocysteinemia physiopathology, Indans pharmacology, Lipid Peroxidation drug effects, Male, Maze Learning drug effects, Neurotoxicity Syndromes blood, Neurotoxicity Syndromes physiopathology, Neurotoxicity Syndromes psychology, Nitric Oxide metabolism, Nitrites blood, Piperidines pharmacology, Rats, Wistar, Time Factors, Vasodilation drug effects, Antioxidants pharmacology, Behavior, Animal drug effects, Brain drug effects, Endothelium, Vascular drug effects, Hesperidin pharmacology, Hyperhomocysteinemia drug therapy, Methionine, Neuroprotective Agents pharmacology, Neurotoxicity Syndromes prevention & control, Oxidative Stress drug effects
- Abstract
Context: Hesperidin (HSP), a flavanoglycone found in citrus fruits, has antioxidant, anti-inflammatory and neuroprotective properties., Objective: This study evaluates the protective effect of HSP on l-methionine-induced hyperhomocysteinemia (HHcy) in rats., Materials and Methods: Male Wistar rats were randomly divided into seven groups as DMSO, l-methionine, HSP (25, 50 and 100 mg/kg), HSP-per se (100 mg/kg) and donepezil (0.1 mg/kg). HHcy was induced by oral administration of l-methionine (1.7 g/kg) for 32 days. From the 14
th day of study HSP (25, 50 and 100 mg/kg) and donepezil was administered orally to l-methionine-treated rats. Cognitive impairment induced by HHcy was determined using the Morris water maze (MWM) and Y-maze on video tracking system (28th -32nd day). Different biomarkers of HHcy in serum and brain and vascular reactivity were evaluated and histopathology (thoracic aorta and brain) was done., Results: HSP (100 mg/kg) treatment in l-methionine-treated rats exhibited significant (p < 0.001) dose-dependent activity and reduced behavioural deficits, brain acetylcholinesterase (25.99 ± 2.36 versus 10.73 ± 1.26 μmoles/mg), brain lipid peroxidation (15.25 ± 1.65 versus 6.18 ± 0.74 nM/mg), serum homocysteine (Hcy) (22.37 ± 0.30 versus 11.01 ± 1.01 μg/mL) and serum cholesterol (182.7 ± 2.15 versus 101.5 ± 2.76 mg/dL) and increased brain antioxidant levels. HSP significantly (p < 0.001) reduced endothelial dysfunction (ED) by abolishing the effect of l-methionine on acetylcholine-induced endothelial-dependent relaxation and increased serum nitrite and vascular nitric oxide bioavailability along with the restoration of histological aberrations., Conclusion: HSP exerts a protective effect on HHcy by abrogating oxidative stress, ED and neurotoxicity.- Published
- 2017
- Full Text
- View/download PDF
49. Severe Hyperhomocysteinemia Decreases Creatine Kinase Activity and Causes Memory Impairment: Neuroprotective Role of Creatine.
- Author
-
Kolling J, Longoni A, Siebert C, Dos Santos TM, Marques EP, Carletti J, Pereira LO, and Wyse ATS
- Subjects
- Animals, Female, Homeostasis drug effects, Hyperhomocysteinemia chemically induced, Male, Memory Disorders prevention & control, Neuroprotection drug effects, Phosphorylation, Rats, Wistar, Creatine pharmacology, Creatine Kinase drug effects, Hippocampus drug effects, Hyperhomocysteinemia drug therapy, Memory drug effects
- Abstract
In the present study, we investigate the effect of severe hyperhomocysteinemia on biochemical (creatine kinase activity), behavioral (memory tests), and histological assessments (hippocampal volume). A possible neuroprotective role of creatine on hyperhomocysteinemia effects was also evaluated. Severe hyperhomocysteinemia was induced in neonate rats (starting at 6 days of age) by treatment with homocysteine (0.3-0.6 μmol/g body weight) for 23 days. Creatine (50 mg/kg body weight) was administered concomitantly with homocysteine. Controls received saline in the same volumes. Twelve hours after the last injection, the rats were submitted to behavioral tests [(recognition task (NOR)] and inhibitory avoidance (IA)]. Following behavioral assessment, the animals were perfused and decapitated, the brain removed for subsequent morphological analysis of the hippocampus. Another group of animals was used to test creatine kinase activity in hippocampus. The results showed that rats treated with homocysteine decreased (44%) the exploration of the novel object in NOR. In the IA task, homocysteine-treated animals presented decreased latencies to step down the platform in short- (32%) and long-term (18%) testings (3 h and 7 days, respectively), evidencing aversive memory impairment. Hippocampal volume was not altered by homocysteine administration. Hyperhomocysteinemia decreased (45%) creatine kinase activity, and creatine was able to prevent such effect probably by creatine kinase/phosphocreatine/creatine homeostasis, which serves as energy circuit within of the cell. This finding may be associated, at least in part, with memory improvement, suggesting that creatine might represent an effective adjuvant to protect against the effects of high homocysteine plasma levels.
- Published
- 2017
- Full Text
- View/download PDF
50. Increased myoendothelial feedback is associated with increased connexin37 and IK1 channel expression in mesenteric arteries of diet-induced hyperhomocysteinemic mice.
- Author
-
Looft-Wilson RC, Goodell CR, Mutch CA, Mutchler SM, Miller KL, and Guraya M
- Subjects
- Animals, Food, Formulated adverse effects, Gap Junctions pathology, Hyperhomocysteinemia chemically induced, Hyperhomocysteinemia pathology, Hyperhomocysteinemia physiopathology, Male, Mesenteric Arteries pathology, Mesenteric Arteries physiopathology, Mice, Nitric Oxide Synthase Type I biosynthesis, Nitric Oxide Synthase Type II biosynthesis, Nitric Oxide Synthase Type III biosynthesis, Gap Junction alpha-4 Protein, Connexins metabolism, Gap Junctions metabolism, Gene Expression Regulation, Hyperhomocysteinemia metabolism, Intermediate-Conductance Calcium-Activated Potassium Channels biosynthesis, Mesenteric Arteries metabolism
- Abstract
Objective: Previously, we found that diet-induced HHcy in mice caused decreased eNOS expression and signaling in mesenteric arteries, but greatly enhanced non-NOS, non-prostacyclin-dependent vasodilation, which involves MEJ communication. To further assess whether HHcy enhances MEJ communication, this study examined endothelium-dependent attenuation of phenylephrine-induced vasoconstriction (myoendothelial feedback) and key molecules involved., Methods: Myoendothelial feedback was examined in isolated mouse mesenteric arteries, after 6-weeks diet-induced HHcy, using pressure myography. Gap junction (Cx37, Cx40, Cx43), NOS (eNOS, nNOS, iNOS), and potassium channel (IK1) protein expression were measured with immunoblots, and connexin mRNAs with real-time PCR. Contribution of nNOS + iNOS to vasomotor responses was assessed using the drug TRIM., Results: Myoendothelial feedback was significantly (P < .05) enhanced in HHcy arteries compared to control, coincident with significantly greater Cx37 and IK1 protein and Cx37 mRNA. Cx43 protein, but not mRNA, was significantly less in HHcy, and Cx40 was not different. eNOS protein was significantly less in HHcy. nNOS and iNOS were not different. TRIM had little effect on vasomotor function., Conclusions: Diet-induced HHcy enhanced myoendothelial feedback, and increased Cx37 and IK1 expression may contribute. nNOS or iNOS did not upregulate to compensate for decreased eNOS, and they had little involvement in vasomotor function., (© 2017 John Wiley & Sons Ltd.)
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.